Processing 00000000.tx.1: Journal of Histochemistry and Cytochemistry, Vol. 

Phrase: "Journal of Histochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "and"

Phrase: "Cytochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010741:Cytochemistry [Biomedical Occupation or Discipline]

Phrase: "Vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449468:VOL [Quantitative Concept]
  1000   C0560268:vol% [Quantitative Concept]
  1000   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.2: 50, 519-526, April 2002, Copyright  2002, The Histochemical Society, Inc. 

Phrase: "50,"

Phrase: "519-526,"

Phrase: "April 2002,"

Phrase: "Copyright  2002,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0009993:Copyright [Intellectual Product]
   861   C1552856:copyright [Idea or Concept]

Phrase: "The Histochemical Society,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037455:society [Organization]

Phrase: "Inc."
Processing 00000000.tx.3: ARTICLE Distribution of Melatonin MT1 Receptor Immunoreactivity in Human Retina Egemen Savaskana, Anna WirzJusticeb, Gianfranco Olivieria, Mona Pachec, Kurt Kruchib, Lena Brydond, Ralf Jockersd, Franz MllerSpahna, and Peter Meyerc a Department of Gerontopsychiatry, Paris, France b Center for Chronobiology, Paris, France c Psychiatric University Clinic and University Eye Clinic, Paris, France d Basel, Switzerland, and Institut Cochin de Gntique Molculaire, Paris, France Correspondence to: Egemen Savaskan, Dept. of Psychiatry, University of Basel, Wilhelm Klein-Str.27, CH-4025 Basel, Switzerland. 

Phrase: "ARTICLE Distribution of Melatonin MT1 Receptor Immunoreactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0520511:distribution [Idea or Concept]
   744   C1704711:Distribution [Functional Concept]

Phrase: "in Human Retina Egemen Savaskana,"

Phrase: "Anna WirzJusticeb,"

Phrase: "Gianfranco Olivieria,"

Phrase: "Mona Pachec,"

Phrase: "Kurt Kruchib,"

Phrase: "Lena Brydond,"

Phrase: "Ralf Jockersd,"

Phrase: "Franz MllerSpahna,"

Phrase: "and"

Phrase: "Peter Meyerc"

Phrase: "a Department of Gerontopsychiatry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "Paris,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030561:Paris [Geographic Area]
  1000   C0331677:Paris [Plant]
  1000   C1824032:PARIS [Gene or Genome]
   966 E C1824369:PARI [Gene or Genome]

Phrase: "France b Center for Chronobiology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205099:Center [Spatial Concept]

Phrase: "Paris,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030561:Paris [Geographic Area]
  1000   C0331677:Paris [Plant]
  1000   C1824032:PARIS [Gene or Genome]
   966 E C1824369:PARI [Gene or Genome]

Phrase: "France c Psychiatric University Clinic"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   817   C1552808:Psychiatry clinic [Intellectual Product]
   804   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   804   C0041740:University [Manufactured Object,Organization]
   804   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   733 E C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "University Eye Clinic,"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   827   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   827   C0015392:Eye [Body Part, Organ, or Organ Component]
   827   C0041740:University [Manufactured Object,Organization]
   827   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   827   C1280202:Eye [Body Part, Organ, or Organ Component]
   771 E C0029144:optic [Occupation or Discipline]
   771 E C0042789:Ocular [Organism Function]
   771 E C1299003:Ocular [Spatial Concept]
   755 E C0205210:Clinical [Qualitative Concept]
   734 E C0014236:Ophthalmia [Disease or Syndrome]
   734 E C0700042:Oculus [Body Location or Region]

Phrase: "Paris,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030561:Paris [Geographic Area]
  1000   C0331677:Paris [Plant]
  1000   C1824032:PARIS [Gene or Genome]
   966 E C1824369:PARI [Gene or Genome]

Phrase: "France d Basel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331779:Basel [Health Care Related Organization]

Phrase: "Switzerland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: "and"

Phrase: "Institut Cochin de Gntique Molculaire,"

Phrase: "Paris,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030561:Paris [Geographic Area]
  1000   C0331677:Paris [Plant]
  1000   C1824032:PARIS [Gene or Genome]
   966 E C1824369:PARI [Gene or Genome]

Phrase: "France Correspondence to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "Egemen Savaskan,"

Phrase: "Dept."

Phrase: "of Psychiatry,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033872:Psychiatry [Professional or Occupational Group]
  1000   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   928 E C0205487:Psychiatric [Functional Concept]

Phrase: "University of Basel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041740:University [Manufactured Object,Organization]
   827   C0331779:Basel [Health Care Related Organization]

Phrase: "Wilhelm Klein-Str.27,"

Phrase: "CH-4025 Basel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331779:Basel [Health Care Related Organization]

Phrase: "Switzerland."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]
Processing 00000000.tx.4: E-mail: esavaskan@datacomm.ch Summary Top Summary Introduction Materials and Methods Results Discussion Literature Cited Melatonin is synthesized in the pineal gland and retina during the night. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "esavaskan@datacomm.ch Summary Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "Melatonin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025219:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
  1000   C1527137:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "is"

Phrase: "synthesized in the pineal gland"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0031939:Pineal gland [Body Part, Organ, or Organ Component]
           Pineal
   806   C1278881:Pineal gland [Body Part, Organ, or Organ Component]
   806   C1519088:GLAND, PINEAL [Tissue]
   760   C1285092:Gland [Body Part, Organ, or Organ Component]
   760   C1883254:Synthesized [Activity]

Phrase: "and"

Phrase: "retina during the night."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035298:Retina [Body Part, Organ, or Organ Component]
   770   C1278894:Retina [Body Part, Organ, or Organ Component]
Processing 00000000.tx.5: Retinal melatonin is believed to be involved in local cellular modulation and in regulation of light-induced entrainment of circadian rhythms. 

Phrase: "Retinal melatonin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025219:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   861   C1527137:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "is"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in local cellular modulation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0544633:Modulation, cellular [Organ or Tissue Function]
   760   C0007634:Cellular [Cell]
   760   C0178539:Cellular [Functional Concept]
   760   C0205276:Local [Spatial Concept]
   760   C0443264:Modulation [Spatial Concept]
   760   C1314939:Involved [Functional Concept]

Phrase: "and in regulation of light-induced entrainment of circadian rhythms."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   786   C1325859:regulation of circadian rhythm [Biologic Function]
   760   C0008810:Circadian Rhythms [Organism Function]
   760   C1522722:Circadian Rhythms [Functional Concept]
   739   C0023693:Light [Natural Phenomenon or Process]
   739   C0205263:Induced [Functional Concept]
   739   C0851285:Regulation [Governmental or Regulatory Activity]
   739   C0871269:rhythms [Finding]
   739   C1306462:Light [Functional Concept]
   739   C1327622:Regulation [Biologic Function]
   739   C1515981:And [Idea or Concept]
   739   C1881376:Light [Qualitative Concept]
   726 E C1522723:Circadian Rhythm [Biologic Function]
   706 E C1523018:rhythm [Physiologic Function]
Processing 00000000.tx.6: The present study provides the first immunohistochemical evidence for the localization of melatonin 1a-receptor (MT1) in human retina of aged subjects. 

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "the first immunohistochemical evidence for the localization of melatonin 1a-receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "(MT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: "in human retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035298:Retina [Body Part, Organ, or Organ Component]
   861   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "of aged subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.7: Ganglion, amacrine, and photoreceptor cells expressed MT1. 

Phrase: "Ganglion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017067:Ganglion [Body Part, Organ, or Organ Component]
  1000   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]

Phrase: "amacrine,"

Phrase: "and"

Phrase: "photoreceptor cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0031760:Photoreceptor Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressed"

Phrase: "MT1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]
Processing 00000000.tx.8: In addition, MT1 immunoreactivity was localized to cell processes in the inner plexiform layer and to central vessels of the retina, as well as to retinal vessels but not to ciliary or choroidal vessels. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "MT1 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "localized to cell processes"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0230625:cell processes [Cell Component]
   816 E C0007613:Cell Process [Cell Function]
   770   C0007634:Cell [Cell]
   770   C0392752:Localized [Spatial Concept]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   737   C1184743:Process [Body Part, Organ, or Organ Component]
   737   C1522240:Process [Phenomenon or Process]

Phrase: "in the inner plexiform layer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1512785:Inner Plexiform Layer [Body Part, Organ, or Organ Component]
   827   C0205102:Inner [Spatial Concept]
   827   C0450207:Plexiform [Spatial Concept]
   827   C0934502:Layer [Body Part, Organ, or Organ Component]
   827   C1522408:Layer [Qualitative Concept]
   827   C1561599:Layer [Intellectual Product]

Phrase: "and to central vessels of the retina,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   793   C1305222:Vessel of retina [Body Part, Organ, or Organ Component]
   774   C0035330:retina vessels [Body Part, Organ, or Organ Component]
   748   C0005847:Vessels [Body Part, Organ, or Organ Component]
   748   C0035298:Retina [Body Part, Organ, or Organ Component]
   748   C0205099:Central [Spatial Concept]
   748   C1278894:Retina [Body Part, Organ, or Organ Component]
   748   C1515981:And [Idea or Concept]
   748   C1879652:Central - [Laboratory Procedure]
   714 E C1511228:Vessel [Tissue]

Phrase: "as well as to retinal vessels"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0035330:Retinal Vessels [Body Part, Organ, or Organ Component]
   753   C0005847:Vessels [Body Part, Organ, or Organ Component]
   753   C0035298:Retinal [Body Part, Organ, or Organ Component]
   753   C0205170:Well [Qualitative Concept]
   753   C3146287:Well [Manufactured Object]
   719 E C1511228:Vessel [Tissue]

Phrase: "but"

Phrase: "not to ciliary"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1518422:Not [Functional Concept]
   734   C0015422:Eyelash [Body Part, Organ, or Organ Component]
   734   C1288305:Eyelash [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "choroidal vessels."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0005847:Vessels [Body Part, Organ, or Organ Component]
   827 E C1511228:Vessel [Tissue]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.9: These results support a variety of cellular and vascular effects of melatonin in the human retina. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "a variety of cellular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1883525:Variety [Conceptual Entity]
   770   C2346866:Variety [Conceptual Entity]

Phrase: "and"

Phrase: "vascular effects of melatonin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "in the human retina."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035298:Retina [Body Part, Organ, or Organ Component]
   861   C1278894:Retina [Body Part, Organ, or Organ Component]
Processing 00000000.tx.10: Preliminary evidence from patients with Alzheimer's disease (AD) revealed increased MT1 immunoreactivity in ganglion and amacrine cells, as well as in vessels. 

Phrase: "Preliminary evidence from patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "with Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "increased MT1 immunoreactivity in ganglion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597879:immunoreactivity [Molecular Function]

Phrase: "and"

Phrase: "amacrine cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0229216:Amacrine Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "as well as in vessels."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0005847:Vessels [Body Part, Organ, or Organ Component]
   760   C0205170:Well [Qualitative Concept]
   760   C3146287:Well [Manufactured Object]
   726 E C1511228:Vessel [Tissue]
Processing 00000000.tx.11: In AD cases photoreceptor cells were degenerated and showed low MT1 expression. 

Phrase: "In AD cases photoreceptor cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0031760:Photoreceptor Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "degenerated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011164:Degenerated [Pathologic Function]
  1000   C1880269:Degenerated [Functional Concept]

Phrase: "and"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "low MT1 expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.12: (J Histochem Cytochem 50:519525, 2002) Key Words: melatonin MT1 receptor, retina, ganglion cell, photoreceptor, amacrine cell, vessels, Alzheimer's disease Introduction Top Summary Introduction Materials and Methods Results Discussion Literature Cited The hormone melatonin, secreted from the pineal gland at night and suppressed by light during the day, provides a circadian and seasonal signal to the organism. 

Phrase: "(J Histochem Cytochem 50"

Phrase: ":"

Phrase: "519525,"

Phrase: "2002"

Phrase: ")"

Phrase: "Key Words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "melatonin MT1 receptor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C0065911:Receptor, Melatonin [Amino Acid, Peptide, or Protein,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "retina,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035298:Retina [Body Part, Organ, or Organ Component]
  1000   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "ganglion cell,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0228071:Ganglion cell [Cell]
   861   C0007634:Cell [Cell]
   861   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   861   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "photoreceptor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031760:Photoreceptor [Cell]

Phrase: "amacrine cell,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0229216:Amacrine cell [Cell]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "vessels,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0005847:Vessels [Body Part, Organ, or Organ Component]
   966 E C1511228:Vessel [Tissue]
   928 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "Alzheimer's disease Introduction Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "The hormone melatonin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025219:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   861   C1527137:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "secreted from the pineal gland"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0031939:Pineal gland [Body Part, Organ, or Organ Component]
           Pineal
   806   C1278881:Pineal gland [Body Part, Organ, or Organ Component]
   806   C1519088:GLAND, PINEAL [Tissue]
   760   C1285092:Gland [Body Part, Organ, or Organ Component]
   760   C1327616:Secreted [Cell Function]

Phrase: "at night"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0240526:Night [Temporal Concept]

Phrase: "and"

Phrase: "suppressed by light"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0023693:Light [Natural Phenomenon or Process]
   790   C1260953:Suppressed [Functional Concept]
   790   C1306462:Light [Functional Concept]
   790   C1881376:Light [Qualitative Concept]

Phrase: "during the day,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332173:/day [Temporal Concept]
  1000   C0439228:day [Temporal Concept]
  1000   C0439505:/day [Temporal Concept]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a circadian"

Phrase: "and"

Phrase: "seasonal signal to the organism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.13: The circadian rhythm is generated by the suprachiasmatic nucleus (SCN). 

Phrase: "The circadian rhythm"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0008810:Circadian Rhythm [Organism Function]
  1000   C1522723:Circadian Rhythm [Biologic Function]
   861   C0871269:Rhythm [Finding]
   861   C1523018:rhythm [Physiologic Function]
   761 E C0031084:Rhythmicities [Temporal Concept]

Phrase: "is"

Phrase: "generated by the suprachiasmatic nucleus (SCN)."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0038866:Suprachiasmatic Nucleus [Body Part, Organ, or Organ Component]
   806   C1289559:Suprachiasmatic nucleus [Body Location or Region]
   760   C0007610:Nucleus [Cell Component]
   760   C3146294:Generated [Activity]
Processing 00000000.tx.14: Light information to the SCN is transduced via the retina, itself containing a circadian pacemaker (Terman et al. 1991 ; Herzog and Block 1999 ; Tosini 2000 ) which drives the rhythm of local melatonin synthesis. 

Phrase: "Light information to the SCN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1533716:Information [Idea or Concept]

Phrase: "is"

Phrase: "transduced via the retina,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035298:Retina [Body Part, Organ, or Organ Component]
   770   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "itself"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a circadian pacemaker"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030163:pacemaker [Medical Device]
   861   C1546728:Pacemaker [Intellectual Product]
   861   C3275122:PACEMAKER [Therapeutic or Preventive Procedure]

Phrase: "(Terman et al. 1991"

Phrase: "; Herzog"

Phrase: "and"

Phrase: "Block 1999"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0028778:Block [Pathologic Function]
   861   C0332206:Block [Functional Concept]
   861   C1533157:Block [Substance]
   861   C1706084:Block [Geographic Area]
   861   C2828370:Block [Quantitative Concept]
   789 E C2983591:BLOCKED [Research Activity]

Phrase: "; Tosini 2000"

Phrase: ")"

Phrase: "which"

Phrase: "drives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "the rhythm of local melatonin synthesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871269:Rhythm [Finding]
   753   C1523018:rhythm [Physiologic Function]
Processing 00000000.tx.15: The function of melatonin in the human retina is not well known. 

Phrase: "The function of melatonin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "in the human retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035298:Retina [Body Part, Organ, or Organ Component]
   861   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "not well known."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0439673:Not Known [Qualitative Concept]
   827   C0205170:Well [Qualitative Concept]
   827   C0205309:Known [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]
Processing 00000000.tx.16: In vertebrates, melatonin mediates dark-adaptive regulation of retinomotor movements (Pierce and Besharse 1985 ), circadian disc shedding in photoreceptor cells (White and Fisher 1989 ), regulation of horizontal cell sensitivity to light (Wiechmann et al. 1988 ), and modulation of dopamine release (Dubocovich 1983 ). 

Phrase: "In vertebrates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042567:Vertebrates [Vertebrate]

Phrase: "melatonin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025219:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
  1000   C1527137:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "dark-adaptive regulation of retinomotor movements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "(Pierce"

Phrase: "and"

Phrase: "Besharse 1985"

Phrase: ")"

Phrase: ","

Phrase: "circadian disc shedding in photoreceptor cells"

Phrase: "(White"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "and"

Phrase: "Fisher 1989"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325045:Fisher [Mammal]

Phrase: ")"

Phrase: ","

Phrase: "regulation of horizontal cell sensitivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "to light"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023693:Light [Natural Phenomenon or Process]
  1000   C1306462:Light [Functional Concept]
  1000   C1881376:Light [Qualitative Concept]

Phrase: "(Wiechmann et al. 1988"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "modulation of dopamine release"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0443264:Modulation [Spatial Concept]

Phrase: "(Dubocovich 1983"

Phrase: ")."
Processing 00000000.tx.17: The melatonin-synthesizing enzymes are found in photoreceptor cells, rods and cones (Wiechmann and Hollyfield 1989 ; Tosini 2000 ). 

Phrase: "The melatonin-synthesizing enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014442:Enzymes [Enzyme,Organic Chemical]
   827   C0014445:enzymes [Functional Concept]

Phrase: "are"

Phrase: "found in photoreceptor cells,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   833   C0031760:Photoreceptor Cells [Cell]
           Photoreceptor
   770   C0007634:Cells [Cell]
   770   C0150312:Found [Quantitative Concept]
   770   C3282337:Cells [Cell]
   737 E C0243095:Find [Finding]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "rods"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0206427:Rods [Cell]
   966 E C1552915:rod [Quantitative Concept]
   966 E C1705186:Rod [Medical Device]
   966 E C1947942:Rod [Spatial Concept]
   966 E C2347970:rod [Quantitative Concept]
   966 E C2347971:rod [Quantitative Concept]

Phrase: "and"

Phrase: "cones"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0206428:Cones [Cell]
   966 E C0330095:Cone [Plant]
   966 E C2350017:Cone [Spatial Concept]

Phrase: "(Wiechmann"

Phrase: "and"

Phrase: "Hollyfield 1989"

Phrase: "; Tosini 2000"

Phrase: ")."
Processing 00000000.tx.18: As in the pineal, melatonin in the retina may act as a signal of darkness. 

Phrase: "As in the pineal, melatonin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025219:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0031939:Pineal [Body Part, Organ, or Organ Component]
   760   C1527137:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "in the retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035298:Retina [Body Part, Organ, or Organ Component]
  1000   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "may"

Phrase: "act as a signal of darkness."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010986:Darkness [Natural Phenomenon or Process]
   753   C0079613:ACT [Therapeutic or Preventive Procedure]
   753   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.19: Melatonin has another characteristic. 

Phrase: "Melatonin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025219:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
  1000   C1527137:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "has"

Phrase: "another characteristic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521970:Characteristic [Qualitative Concept]
Processing 00000000.tx.20: It is a highly potent antioxidative substance, reducing the damage caused by free radicals generated not only by light, but also by amyloid -peptide, which is crucially involved in the neuropathology seen in several cognitively disabling neurodegenerative diseases such as Alzheimer's disease (AD) (Pappolla et al. 2000 ). 

Phrase: "It"

Phrase: "is"

Phrase: "a highly potent antioxidative substance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439861:Substance [Substance]

Phrase: "reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "the damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010957:Damage [Injury or Poisoning]
  1000   C1883709:Damage [Functional Concept]

Phrase: "caused by free radicals"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   770   C0302912:radicals [Chemical Viewed Structurally]
   770   C0332296:free [Functional Concept]
   770   C1880497:Free [Qualitative Concept]
   770   C1996904:Free [Qualitative Concept]
   737   C0015127:cause [Functional Concept]
   737 E C0439807:Radical [Qualitative Concept]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "not only by light,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0023693:Light [Natural Phenomenon or Process]
   770   C0205171:Only [Quantitative Concept]
   770   C1306462:Light [Functional Concept]
   770   C1518422:Not [Functional Concept]
   770   C1720467:Only [Intellectual Product]
   770   C1881376:Light [Qualitative Concept]

Phrase: "but"

Phrase: "also by amyloid -peptide,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "is"

Phrase: "crucially"

Phrase: "involved in the neuropathology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   770   C1314939:Involved [Functional Concept]
   770   C1540677:neuropathology [Pathologic Function]
   770   C1555824:Neuropathology [Intellectual Product]

Phrase: "seen in several cognitively disabling neurodegenerative diseases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   778   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   757   C0596452:disabling disease [Disease or Syndrome]
   748   C0012634:Diseases [Disease or Syndrome]
   748   C0205397:Seen [Qualitative Concept]
   714 E C0042789:see [Organism Function]
   714 E C1947903:See [Activity]

Phrase: "such as Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD) (Pappolla et al. 2000"

Phrase: ")."
Processing 00000000.tx.21: In mammals, the specific actions of melatonin are mediated by two different subtypes of G-protein-coupled receptors, the melatonin 1a (MT1) and melatonin 1b (MT2) receptors (Brydon et al. 1999 ; Dubocovich et al. 2000 ). 

Phrase: "In mammals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024660:Mammals [Mammal]

Phrase: "the specific actions of melatonin"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0205369:Specific [Qualitative Concept]
   760   C0441472:actions [Functional Concept]
   760   C1552740:specific [Intellectual Product]
   726 E C3266814:Action [Activity]

Phrase: "are"

Phrase: "mediated by two different subtypes of G-protein-coupled receptors,"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   806   C0682972:G-Protein-Coupled Receptors [Amino Acid, Peptide, or Protein,Receptor]
   760   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   757 E C0060916:protein g [Amino Acid, Peptide, or Protein]
   757   C0597357:protein receptors [Amino Acid, Peptide, or Protein,Receptor]
           receptors
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0086597:mediated [Social Behavior]
   739   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   739   C0205448:Two [Quantitative Concept]
   739   C0439267:g% [Quantitative Concept]
   739   C0449560:subtypes [Classification]
   739   C1705242:Different [Qualitative Concept]
   739   C1948027:Coupled [Functional Concept]
   706 E C0010222:couple [Family Group]

Phrase: "the melatonin 1a (MT1)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "melatonin 1b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "(MT2"

Phrase: ")"

Phrase: "receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(Brydon et al. 1999"

Phrase: "; Dubocovich et al. 2000"

Phrase: ")."
Processing 00000000.tx.22: Specific polyclonal antibodies are available against MT1 (Brydon et al. 1999 ). 

Phrase: "Specific polyclonal antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   896   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   867   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "are"

Phrase: "available against MT1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0470187:Available [Functional Concept]

Phrase: "(Brydon et al. 1999"

Phrase: ")."
Processing 00000000.tx.23: Its expression has been studied in rodents using immunocytochemistry and in situ hybridization (Fujieda et al. 1999 , Fujieda et al. 2000 ). 

Phrase: "Its expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "studied in rodents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0035804:Rodents [Mammal]
   756   C0557651:Study [Manufactured Object]
   756   C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "immunocytochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242349:Immunocytochemistry [Laboratory Procedure]

Phrase: "and"

Phrase: "in situ hybridization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   901   C0444498:In situ [Spatial Concept]
   827   C0020202:Hybridisation [Genetic Function]
   827   C1300517:Hybridization [Laboratory Procedure]

Phrase: "(Fujieda et al. 1999 ,"

Phrase: "Fujieda et al. 2000"

Phrase: ")."
Processing 00000000.tx.24: However, corresponding studies in humans remain to be done. 

Phrase: "However,"

Phrase: "corresponding"

Phrase: "studies in humans"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   858   C0178693:humans studies [Research Activity]
   790   C0947630:studies [Laboratory Procedure]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]

Phrase: "remain"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "done."
Processing 00000000.tx.25: In recent studies we were able to show localization of MT1 in humans in cerebrovascular tissue emphasizing melatonin's vasoactive properties (Savaskan et al. 2001 ) and in hippocampal neurons (Savaskan et al. in press ). 

Phrase: "In recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "localization of MT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "in humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "in cerebrovascular tissue emphasizing melatonin's vasoactive properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   799   C0871161:properties [Qualitative Concept]
   799   C1292721:properties [Functional Concept]
   766 E C1882134:Property [Conceptual Entity]
   766 E C2347695:Property [Entity]

Phrase: "(Savaskan et al. 2001"

Phrase: ")"

Phrase: "and in hippocampal neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   770   C0027882:Neurons [Cell]
   770   C1515981:And [Idea or Concept]

Phrase: "(Savaskan et al."

Phrase: "in press"

Phrase: ")."
Processing 00000000.tx.26: The aim of this study was to provide immunohistochemical evidence, the first we are aware of, for the distribution of MT1 in human retina and in the ocular vascular system. 

Phrase: "The aim of this study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1947946:Aim [Idea or Concept]
   760   C2948600:Aim [Pharmacologic Substance]
   760   C3540471:AIM [Gene or Genome]
   760   C3540472:AIM [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "immunohistochemical evidence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "the first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "we"

Phrase: "are"

Phrase: "aware of,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0004448:Aware [Mental Process]

Phrase: "for the distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0520511:distribution [Idea or Concept]
  1000   C1704711:Distribution [Functional Concept]

Phrase: "of MT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "in human retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035298:Retina [Body Part, Organ, or Organ Component]
   861   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "and in the ocular vascular system."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   790   C0489903:Vascular System [Body System]
   783   C2347385:Ocular System [Biomedical or Dental Material]
   783   C2347386:Ocular System [Quantitative Concept]
   762   C1276272:Ocular blood vessel [Body Part, Organ, or Organ Component]
   753   C0005847:vascular [Body Part, Organ, or Organ Component]
   753   C0015392:Ocular [Body Part, Organ, or Organ Component]
   753   C0042789:Ocular [Organism Function]
   753   C0449913:System [Functional Concept]
   753   C1299003:Ocular [Spatial Concept]
   753   C1515981:And [Idea or Concept]
   753   C1553451:System [Manufactured Object]
   753   C1558950:VASCULAR [Finding]
   753   C1704459:System [Medical Device]
   753   C1801960:Vascular [Qualitative Concept]
   734 E C0242201:Hemic System [Body System]
Processing 00000000.tx.27: In addition, eyes of two AD patients were included in the study as a preliminary investigation of possible alterations in the disease process. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "eyes of two AD patients"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0015392:Eyes [Body Part, Organ, or Organ Component]
   726 E C1280202:Eye [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "included in the study"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0332257:included [Functional Concept]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: "as a preliminary investigation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C1261322:Investigation [Health Care Activity]
   861   C1552578:investigation [Idea or Concept]
   789 E C1517586:Investigational [Qualitative Concept]
   789 E C3245491:investigational [Intellectual Product]

Phrase: "of possible alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1515926:Alteration [Idea or Concept]

Phrase: "in the disease process."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.28: Materials and Methods Top Summary Introduction Materials and Methods Results Discussion Literature Cited Human Tissue Paraffin-embedded human eyes fixed in 4% paraformaldehyde were obtained from seven subjects without neurological or psychiatric disease (six women and one man, mean age 83.1  9.8 years and two male AD cases, 83 and 84 years old. The mean postmortem delay was 21 hr and 31 min  9 hr and 10 min) for controls and 16 hr and 15 min for AD cases (Table 1). 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "Human Tissue Paraffin-embedded human eyes"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   799   C0015392:Eyes [Body Part, Organ, or Organ Component]
   766 E C1280202:Eye [Body Part, Organ, or Organ Component]
   727 E C0029144:optic [Occupation or Discipline]
   727 E C0042789:Ocular [Organism Function]
   727 E C1299003:Ocular [Spatial Concept]

Phrase: "fixed in 4% paraformaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "were"

Phrase: "obtained from seven"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205453:Seven [Quantitative Concept]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "subjects without neurological"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0205494:Neurological [Qualitative Concept]
   790   C0681850:Subject [Group]
   790   C1550501:{Subject} [Idea or Concept]
   790   C1706203:Subject [Idea or Concept]
   790   C2349001:Subject [Human]
   790   C2697811:Subject [Functional Concept]
   790   C2707261:Neurological [Clinical Attribute]

Phrase: "or"

Phrase: "psychiatric disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0004936:Psychiatric Disease [Mental or Behavioral Dysfunction]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(six women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043210:Women [Population Group]

Phrase: "and"

Phrase: "one man, mean age 83.1  9.8 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   854   C1510829:Age-Years [Temporal Concept]
   791   C0439234:years [Temporal Concept]
   758 E C0439508:/year [Temporal Concept]

Phrase: "and"

Phrase: "two male AD cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0868928:Cases [Functional Concept]
   812   C1533148:Cases [Quantitative Concept]
   779 E C1706255:CASE [Medical Device]
   779 E C1706256:Case [Conceptual Entity]

Phrase: "83"

Phrase: "and"

Phrase: "84 years old."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0580836:Old [Temporal Concept]

Phrase: "The mean postmortem delay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205421:Delay [Temporal Concept]

Phrase: "was"

Phrase: "21 hr"

Phrase: "and"

Phrase: "31 min  9 hr"

Phrase: "and"

Phrase: "10 min) for controls"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0456692:/10 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "16 hr"

Phrase: "and"

Phrase: "15 min for AD cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0702093:/min [Temporal Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.29: The diagnosis of AD was made with clinical evaluation and confirmed by postmortem neuropathological examination.

Phrase: "The diagnosis of AD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011900:Diagnosis [Finding]
   770   C1704338:diagnosis [Qualitative Concept]
   770   C1704656:DIAGNOSIS [Research Activity]

Phrase: "was"

Phrase: "made with clinical evaluation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1261322:Clinical evaluation [Health Care Activity]
           Evaluation
   833   C1516634:Clinical Evaluation [Research Activity]
   770   C0205210:Clinical [Qualitative Concept]
   770   C0220825:Evaluation [Functional Concept]
   737   C1881534:Make [Functional Concept]

Phrase: "and"

Phrase: "confirmed by postmortem neuropathological examination."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   797   C0004398:Post-Mortem Examination [Diagnostic Procedure]
           postmortem
   760   C0580205:Postmortem [Temporal Concept]
   760   C0750484:Confirmed [Idea or Concept]
   760   C0848632:post mortem [Finding]
   726 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.30: The cause of death in most cases was heart failure or pneumonia, and pancreatitis for one control case (Table 1). 

Phrase: "The cause of death"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   909   C0007465:Cause of Death [Finding]
           Death Cause
   909   C0804771:Cause of death [Clinical Attribute]
   770   C0015127:cause [Functional Concept]
   770   C1524003:Cause [Conceptual Entity]

Phrase: "in most cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "was"

Phrase: "heart failure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0018801:Heart failure [Disease or Syndrome]
  1000   C0018802:Heart Failure [Disease or Syndrome]
   861   C0018787:Heart [Body Part, Organ, or Organ Component]
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]
   861   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "pneumonia,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0032285:Pneumonia [Disease or Syndrome]
   907 E C0024109:LUNGS [Body Part, Organ, or Organ Component]
   907 E C0819757:LUNG [Tissue]
   907 E C1278908:Lung [Body Part, Organ, or Organ Component]
   893 E C2707265:Pulmonary [Clinical Attribute]
   893 E C2709248:Pulmonary [Qualitative Concept]

Phrase: "and"

Phrase: "pancreatitis for one control case"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0030305:Pancreatitis [Disease or Syndrome]
   760   C1963198:Pancreatitis [Finding]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.31: The sample collection was approved by the Ethics Committee criteria and according to the Helsinki Declaration of 1975. 

Phrase: "The sample collection"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0200345:sample collection [Laboratory Procedure]
   861   C1516698:Collection [Functional Concept]
   861   C1704814:Collection [Idea or Concept]
   789 E C1516695:Collected [Idea or Concept]

Phrase: "was"

Phrase: "approved by the Ethics Committee criteria"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0085546:Ethics Committee [Professional or Occupational Group]
   753   C0015000:Ethics [Idea or Concept]
   753   C0205540:Approved [Qualitative Concept]
   753   C0243161:criteria [Intellectual Product]
   753   C1527243:ethics [Idea or Concept]
   753   C2699414:Committee [Group]

Phrase: "and according to the Helsinki Declaration of 1975."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0018898:Declaration of Helsinki [Regulation or Law]
           Helsinki Declaration
   744   C0680240:according [Social Behavior]
   744   C1515981:And [Idea or Concept]
Processing 00000000.tx.32: Tissue samples were cut in the sagittal plane and 4-m-thick consecutive sections were made with a microtome.  

Phrase: "Tissue samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C1292533:Tissue Sample [Tissue]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "cut in the sagittal plane"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0935598:Sagittal plane [Body Location or Region]
           Sagittal
   760   C0000925:Cut [Injury or Poisoning]
   760   C0205129:Sagittal [Spatial Concept]
   760   C0444660:Plane [Spatial Concept]
   760   C1883724:CUT [Phenomenon or Process]

Phrase: "and"

Phrase: "4-"

Phrase: "m-"

Phrase: "thick consecutive sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "made with a microtome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0181856:microtome [Medical Device]
   770   C0700320:microtome [Laboratory Procedure]
   737   C1881534:Make [Functional Concept]
Processing 00000000.tx.33: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.34: Data of control (C) and Alzheimer's disease (AD) casesa Immunohistochemistry The sections were mounted on coated glass slides and deparaffinized. 

Phrase: "Data of control (C)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1511726:Data [Idea or Concept]
   790   C3245479:data [Medical Device]

Phrase: "and"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD) casesa Immunohistochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "The sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "mounted on coated glass slides"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0017596:Glass [Manufactured Object]
   760   C0444330:slides [Research Device]
   760   C0449878:mounted [Finding]
   760   C1522408:Coated [Qualitative Concept]
   760   C1947936:Glass [Medical Device]
   726 E C0181909:Mount [Medical Device]
   726 E C0453946:Coat [Manufactured Object]
   726 E C1705201:Slide [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "deparaffinized."
Processing 00000000.tx.35: Endogenous peroxidase activity was blocked by bathing the sections in 80% methanol, 0.6% H2O2 for 20 min at room temperature (RT). 

Phrase: "Endogenous peroxidase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1151518:peroxidase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "blocked by bathing"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0028778:Blocked [Pathologic Function]
   790   C0150141:Bathing [Therapeutic or Preventive Procedure]
   790   C0332206:Blocked [Functional Concept]
   790   C0518460:Bathing [Finding]
   790   C0541747:bathing [Therapeutic or Preventive Procedure]
   790   C2983591:BLOCKED [Research Activity]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]

Phrase: "the sections in 80% methanol,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0205155:Section [Spatial Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726   C1705191:Section [Physical Object]

Phrase: "0.6% H2O2 for 20 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "at room temperature (RT)."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.36: After several washes in PBS and preincubation in PBS with 3% blocking serum for 30 min the sections were reacted with primary antibody overnight at RT. 

Phrase: "After several washes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441648:Wash [Activity]

Phrase: "in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "and"

Phrase: "preincubation in PBS"

Phrase: "with 3% blocking serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0229671:Serum [Body Substance]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "the sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "reacted with primary antibody overnight"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0205225:Primary [Qualitative Concept]
   760   C0439583:Overnight [Temporal Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]

Phrase: "at RT."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.37: The affinity-purified polyclonal antibody used to specifically detect MT1 was developed against a peptide (peptide 536) corresponding to a sequence found in the C-terminus of the receptor and the antibody recognition of native MT1 has been ascertained (Brydon et al. 1999 ). 

Phrase: "The affinity-purified polyclonal antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "MT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "was"

Phrase: "developed against a peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(peptide 536"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: "corresponding to a sequence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]

Phrase: "found in the C-terminus of the receptor"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   744   C0150312:Found [Quantitative Concept]
   744   C0243148:control [Qualitative Concept]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]
   711 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "the antibody recognition of native MT1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0524637:Recognition [Mental Process]

Phrase: "has"

Phrase: "been"

Phrase: "ascertained"

Phrase: "(Brydon et al. 1999"

Phrase: ")."
Processing 00000000.tx.38: The non-commercial antibody was kindly provided by L. 

Phrase: "The non-commercial antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "kindly"

Phrase: "provided by L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1999230:Provided [Activity]
Processing 00000000.tx.39: Brydon and R. 

Phrase: "Brydon"

Phrase: "and"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.40: Jockers (Institut Cochin de Gntique Moleculaire; Paris, France). 

Phrase: "Jockers"

Phrase: "(Institut Cochin de Gntique Moleculaire"

Phrase: "; Paris,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030561:Paris [Geographic Area]
  1000   C0331677:Paris [Plant]
  1000   C1824032:PARIS [Gene or Genome]
   966 E C1824369:PARI [Gene or Genome]

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ")."
Processing 00000000.tx.41: In addition, the antibody has been applied successfully in previous immunohistochemical experiments (Savaskan et al. 2001 ; Savaskan et al. in press ). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "successfully in previous immunohistochemical experiments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0205156:Previous [Temporal Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1441616:Immunohistochemical [Laboratory Procedure]
   760   C1552607:previous [Temporal Concept]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "(Savaskan et al. 2001"

Phrase: "; Savaskan et al."

Phrase: "in press"

Phrase: ")."
Processing 00000000.tx.42: The optimal concentration of the primary antibody was experimentally determined to be 1:100. 

Phrase: "The optimal concentration of the primary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "experimentally"

Phrase: "determined"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100."
Processing 00000000.tx.43: In a second step, after several washes with PBS the sections were incubated with biotinylated secondary antibody (Vector Laboratories; Burlingame, CA). 

Phrase: "In a second step,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: "after"

Phrase: "several washes with PBS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0441648:Wash [Activity]

Phrase: "the sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated with biotinylated secondary antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0027627:secondary [Neoplastic Process]
   760   C0175668:Secondary [Temporal Concept]
   760   C0205436:Secondary [Quantitative Concept]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "(Vector Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "; Burlingame,"

Phrase: "CA)."
Processing 00000000.tx.44: The optimal dilution of the secondary antibody was 1:100. 

Phrase: "The optimal dilution of the secondary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0079240:Dilution [Laboratory Procedure]
   748   C1948037:Dilution [Functional Concept]

Phrase: "was"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100."
Processing 00000000.tx.45: After several washes, a pre-formed ABC reagent (Vectastain; Vector Laboratories) was conjugated to the free biotin of the secondary antibody. 

Phrase: "After several washes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441648:Wash [Activity]

Phrase: "a"

Phrase: "pre-formed"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0205431:Formed [Functional Concept]
   861   C0332152:Pre [Temporal Concept]
   861   C0740175:Pre [Qualitative Concept]
   861   C2257086:PRE [Genetic Function]
   827 E C0348078:Form [Qualitative Concept]
   827 E C0376315:Form [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "ABC reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Vectastain"

Phrase: "; Vector Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: "was"

Phrase: "conjugated to the free biotin of the secondary antibody."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   762   C0175668:Secondary to [Temporal Concept]
           Secondary
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0027627:secondary [Neoplastic Process]
   742   C0205436:Secondary [Quantitative Concept]
   742   C0332296:free [Functional Concept]
   742   C0522529:Conjugated [Spatial Concept]
   742   C1880497:Free [Qualitative Concept]
   742   C1996904:Free [Qualitative Concept]
   742   C2700256:Biotin [Laboratory Procedure]
   708 E C0301869:Conjugate [Immunologic Factor]
Processing 00000000.tx.46: The antigen was visualized using the peroxidase substrate 3-amino-9-ethylcarbazole (ACE). 

Phrase: "The antigen"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigen [Immunologic Factor]
   900 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "was"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the peroxidase substrate 3-amino-9-ethylcarbazole"

Phrase: "(ACE"

Phrase: ")."
Processing 00000000.tx.47: The samples were then counterstained with Mayer's hemalum. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "counterstained with Mayer's hemalum."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0065758:Mayer's hemalum [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.48: The sections were coverslipped with Kaiser's glycerol gelatin. 

Phrase: "The sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "coverslipped with Kaiser's glycerol gelatin."
Processing 00000000.tx.49: To test the specificity of the antibody, control sections were stained simultaneously following the same procedure, with the exception that the primary antibody was omitted. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the specificity of the antibody,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   797   C0003264:Antibody Specificity [Molecular Function]
   762 E C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]

Phrase: "control sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "simultaneously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521115:simultaneously [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the same procedure,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "with the exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1554961:exception [Idea or Concept]
  1000   C1705847:Exception [Conceptual Entity]

Phrase: "that"

Phrase: "the primary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "omitted."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750563:omitted [Idea or Concept]
Processing 00000000.tx.50: All sections were assessed for localization and intensity of specific immunoreactivity on a semiquantitative scale of +/+++ by two blinded observers (Table 2).  

Phrase: "All sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "assessed for localization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0475264:Localisation [Functional Concept]
   790   C1516048:Assessed [Activity]
   790   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "intensity of specific immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0522510:Intensity [Qualitative Concept]

Phrase: "on a semiquantitative scale of +/+++"

Phrase: "by two blinded observers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0870992:observers [Professional or Occupational Group]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.51: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.52: Distribution and intensity of MT1 immunoreactivity in human retina in controls (C) and Alzheimer's disease patients (AD)a,b Results Top Summary Introduction Materials and Methods Results Discussion Literature Cited The cytoarchitectural classification regarding cells, different layers, and vascularization in this section follows detailed descriptions by Spencer 1996 . Cellular Structures Different cells within the retina displayed specific MT1 immunoreactivity (Fig 1A1D), whereas adjacent control sections omitting the primary antibody revealed no immune reaction (Fig 1E and Fig 1F). 

Phrase: "Distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0520511:distribution [Idea or Concept]
  1000   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "intensity of MT1 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0522510:Intensity [Qualitative Concept]

Phrase: "in human retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035298:Retina [Body Part, Organ, or Organ Component]
   861   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "in controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "(C"

Phrase: ")"

Phrase: "and"

Phrase: "Alzheimer's disease patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "(AD)a,b Results Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "The cytoarchitectural classification regarding cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "different layers,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0934502:layers [Body Part, Organ, or Organ Component]
   827 E C1522408:Layer [Qualitative Concept]
   827 E C1561599:Layer [Intellectual Product]

Phrase: "and"

Phrase: "vascularization in this section"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0027686:Vascularisation [Pathologic Function]
   770   C0042382:Vascularisation [Functional Concept]

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "detailed descriptions by Spencer 1996 . Cellular Structures Different cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0678257:descriptions [Idea or Concept]

Phrase: "within the retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035298:Retina [Body Part, Organ, or Organ Component]
  1000   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "specific MT1 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0597879:immunoreactivity [Molecular Function]

Phrase: "(Fig 1A1D"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "adjacent control sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "omitting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750563:omitting [Idea or Concept]

Phrase: "the primary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "no immune reaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439662:Immune [Functional Concept]
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "(Fig 1E"

Phrase: "and"

Phrase: "Fig 1F"

Phrase: ")."
Processing 00000000.tx.53: The majority of ganglion cells were immunoreactive for MT1 in their somata and dendritic processes, both in controls and in AD cases (Fig 1A and Fig 1C). 

Phrase: "The majority of ganglion cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "were"

Phrase: "immunoreactive for MT1"

Phrase: "in their somata"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0599444:soma [Cell Component]
   966   C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   928 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]
   900 E C2986476:Somatic [Qualitative Concept]

Phrase: "and"

Phrase: "dendritic processes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0011305:Dendritic [Cell Component]
   861   C0439640:Dendritic [Qualitative Concept]
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "both in controls"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0238767:Both [Spatial Concept]
   790   C1706086:Both [Qualitative Concept]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "and in AD cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0868928:Cases [Functional Concept]
   770   C1515981:And [Idea or Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "(Fig 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "Fig 1C"

Phrase: ")."
Processing 00000000.tx.54: Staining was homogeneously distributed in the perinuclear area. 

Phrase: "Staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "homogeneously"

Phrase: "distributed in the perinuclear area."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0017446:Area [Geographic Area]
   760   C0205146:Area [Spatial Concept]
   760   C1704711:Distributed [Functional Concept]
Processing 00000000.tx.55: In five control cases (Table 1), single MT1-immunoreactive amacrine cells were located in the inner nuclear layer immediately adjacent to the inner plexiform layer. 

Phrase: "In five control cases"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   827   C0243148:control [Qualitative Concept]
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "single MT1-immunoreactive amacrine cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0229216:Amacrine Cells [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "located in the inner nuclear layer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1512784:Inner Nuclear Layer [Body Part, Organ, or Organ Component]
   753   C0205102:Inner [Spatial Concept]
   753   C0521447:Nuclear [Spatial Concept]
   753   C0934502:Layer [Body Part, Organ, or Organ Component]
   753   C1522408:Layer [Qualitative Concept]
   753   C1561599:Layer [Intellectual Product]

Phrase: "immediately adjacent to the inner plexiform layer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0205117:Adjacent to [Spatial Concept]
           Adjacent
Processing 00000000.tx.56: Only a minor subset of amacrine cells were stained. 

Phrase: "Only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a minor subset of amacrine cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1515021:Subset [Classification]

Phrase: "were"

Phrase: "stained."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.57: In all cases there was a slight granular MT1 labeling in the inner plexiform layer located on cell processes. 

Phrase: "In all cases there"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "was"

Phrase: "a slight granular MT1 labeling in the inner plexiform layer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C1167624:Labeling [Mental Process]
   738   C1947902:Labeling [Manufactured Object]
   738   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "located on cell processes."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0230625:cell processes [Cell Component]
   816 E C0007613:Cell Process [Cell Function]
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   737   C1184743:Process [Body Part, Organ, or Organ Component]
   737   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.58: The outer plexiform layer and the horizontal cells were not immunolabeled. 

Phrase: "The outer plexiform layer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0229217:Outer Plexiform Layer [Body Part, Organ, or Organ Component]
   827   C0205101:Outer [Spatial Concept]
   827   C0450207:Plexiform [Spatial Concept]
   827   C0934502:Layer [Body Part, Organ, or Organ Component]
   827   C1522408:Layer [Qualitative Concept]
   827   C1561599:Layer [Intellectual Product]

Phrase: "and"

Phrase: "the horizontal cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   966   C0596713:horizontal cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0205126:Horizontal [Spatial Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "immunolabeled."
Processing 00000000.tx.59: Photoreceptor cells revealed distinct MT1 immunoreactivity in their inner segments (Fig 1B). 

Phrase: "Photoreceptor cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0031760:Photoreceptor Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "distinct MT1 immunoreactivity in their inner segments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0597879:immunoreactivity [Molecular Function]

Phrase: "(Fig 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.60: Cell somata and outer segments were excluded. 

Phrase: "Cell somata"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   983   C0599444:Cell soma [Cell Component]
           soma
   983   C2752549:cell soma [Cell Component]
   827   C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   789 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]
   761 E C2986476:Somatic [Qualitative Concept]

Phrase: "and"

Phrase: "outer segments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205101:Outer [Spatial Concept]
   827   C0441635:Segment [Spatial Concept]
   777 E C0205122:Segmental [Spatial Concept]

Phrase: "were"

Phrase: "excluded."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.61: All photoreceptor cells were stained so that MT1 extended as an immunoreactive band throughout the photoreceptor cell layer. 

Phrase: "All photoreceptor cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0031760:Photoreceptor Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that MT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "extended as an immunoreactive band"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0175723:Band [Medical Device]
   760   C0231448:Extended [Functional Concept]
   760   C0231449:Extended [Spatial Concept]
   760   C0439645:Band [Spatial Concept]
   760   C0439792:extended [Spatial Concept]
   760   C1521913:band [Cell Component]

Phrase: "throughout the photoreceptor cell layer."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0934502:Layer [Body Part, Organ, or Organ Component]
   827   C1522408:Layer [Qualitative Concept]
   827   C1561599:Layer [Intellectual Product]
   734   C0031760:Photoreceptor cell [Cell]
Processing 00000000.tx.62: View larger version (150K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(150K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.63: Sagittal sections through the human retina. 

Phrase: "Sagittal sections through the human retina."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205129:Sagittal [Spatial Concept]
   753   C0935598:Sagittal [Body Location or Region]
   719   C0205155:Section [Spatial Concept]
   719   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   719   C1522472:Section [Substance]
   719   C1552923:Section [Quantitative Concept]
   719   C1705191:Section [Physical Object]
Processing 00000000.tx.64: GCL, ganglion cell layer; 

Phrase: "GCL,"

Phrase: "ganglion cell layer"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0229218:Ganglion cell layer [Body Part, Organ, or Organ Component]
   901   C0228071:Ganglion cell [Cell]
   877   C1517447:Ganglionic Layer [Tissue]
   827   C0007634:Cell [Cell]
   827   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   827   C0934502:Layer [Body Part, Organ, or Organ Component]
   827   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   827   C1269647:Cell [Cell]
   827   C1522408:Layer [Qualitative Concept]
   827   C1561599:Layer [Intellectual Product]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.65: IPL, inner plexiform layer; 

Phrase: "IPL,"

Phrase: "inner plexiform layer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1512785:Inner Plexiform Layer [Body Part, Organ, or Organ Component]
   827   C0205102:Inner [Spatial Concept]
   827   C0450207:Plexiform [Spatial Concept]
   827   C0934502:Layer [Body Part, Organ, or Organ Component]
   827   C1522408:Layer [Qualitative Concept]
   827   C1561599:Layer [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.66: INL, inner nucleiform layer; 

Phrase: "INL,"

Phrase: "inner nucleiform layer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0934502:Layer [Body Part, Organ, or Organ Component]
   827   C1522408:Layer [Qualitative Concept]
   827   C1561599:Layer [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.67: OPL, outer plexiform layer; 

Phrase: "OPL,"

Phrase: "outer plexiform layer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0229217:Outer Plexiform Layer [Body Part, Organ, or Organ Component]
   827   C0205101:Outer [Spatial Concept]
   827   C0450207:Plexiform [Spatial Concept]
   827   C0934502:Layer [Body Part, Organ, or Organ Component]
   827   C1522408:Layer [Qualitative Concept]
   827   C1561599:Layer [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.68: ONL, outer nucleiform layer consisting of cell somata of photoreceptor cells; 

Phrase: "ONL,"

Phrase: "outer nucleiform layer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0934502:Layer [Body Part, Organ, or Organ Component]
   827   C1522408:Layer [Qualitative Concept]
   827   C1561599:Layer [Intellectual Product]

Phrase: "consisting of cell somata of photoreceptor cells"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   778   C0031760:Photoreceptor Cells [Cell]
           Photoreceptor cell
           Photoreceptor
   762   C0599444:Cell soma [Cell Component]
           soma
   762   C2752549:cell soma [Cell Component]
   748   C0007634:Cell [Cell]
           Cells
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3282337:Cells [Cell]
   724 E C1257909:Somatic cell [Cell]
           Somatic cells
   714   C0332529:CONSIST [Qualitative Concept]
   714   C0702216:Soma [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.69: IS, inner segments; 

Phrase: "IS"

Phrase: ","

Phrase: "inner segments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205102:Inner [Spatial Concept]
   827   C0441635:Segment [Spatial Concept]
   777 E C0205122:Segmental [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.70: OS, outer segments of photoreceptor cells; 

Phrase: "OS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0230028:Os [Body Location or Region]
  1000   C0262950:Os [Body Part, Organ, or Organ Component]
  1000   C1561953:Os [Body Part, Organ, or Organ Component]

Phrase: "outer segments of photoreceptor cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1325525:photoreceptor outer segment [Cell Component]
   764   C2332214:Cell segment [Cell Component]
   760   C0205101:Outer [Spatial Concept]
   726   C0441635:Segment [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.71: g, ganglion cells; 

Phrase: "g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "ganglion cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0228071:Ganglion Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   861   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.72: a, amacrine cells; 

Phrase: "a,"

Phrase: "amacrine cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0229216:Amacrine Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.73: p, photoreceptor cells. 

Phrase: "p,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "photoreceptor cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0031760:Photoreceptor Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.74: (A) Ganglion cells show MT1 immunoreactivity as a red deposit in a control case. 

Phrase: "(A) Ganglion cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0228071:Ganglion Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   827   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "MT1 immunoreactivity as a red deposit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597879:immunoreactivity [Molecular Function]

Phrase: "in a control case."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0243148:control [Qualitative Concept]
   861   C0868928:Case [Functional Concept]
   861   C1550141:Control [Substance]
   861   C1706255:CASE [Medical Device]
   861   C1706256:Case [Conceptual Entity]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.75: (B) The IS of photoreceptor cells are distinctly immunopositive for MT1 in a control case. 

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "The"

Phrase: "IS of photoreceptor cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0031760:Photoreceptor Cells [Cell]
           Photoreceptor
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "distinctly immunopositive for MT1"

Phrase: "in a control case."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0243148:control [Qualitative Concept]
   861   C0868928:Case [Functional Concept]
   861   C1550141:Control [Substance]
   861   C1706255:CASE [Medical Device]
   861   C1706256:Case [Conceptual Entity]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.76: (C) The staining intensity is increased in an AD case. 

Phrase: "(C"

Phrase: ")"

Phrase: "The staining intensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522510:Intensity [Qualitative Concept]

Phrase: "is"

Phrase: "increased in an AD case."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0868928:Case [Functional Concept]
   760   C1706255:CASE [Medical Device]
   760   C1706256:Case [Conceptual Entity]
Processing 00000000.tx.77: Note that the IPL, and not the OPL, exhibits MT1 immunoreactivity, and some amacrine cells are strongly MT1 positive, as indicated by arrows. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the IPL,"

Phrase: "and"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the OPL,"

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "MT1 immunoreactivity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597879:immunoreactivity [Molecular Function]

Phrase: "and"

Phrase: "some amacrine cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0229216:Amacrine Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "strongly MT1 positive,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0439178:% Positive [Quantitative Concept]
   812   C1446409:Positive [Qualitative Concept]
   812   C1514241:Positive [Finding]
   812   C2825490:Positive [Qualitative Concept]

Phrase: "as"

Phrase: "indicated by arrows."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0336721:arrows [Manufactured Object]
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.78: (D) The MT1 staining intensity in photoreceptor cells is decreased in an AD case. 

Phrase: "("

Phrase: "D)"

Phrase: "The MT1 staining intensity in photoreceptor cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0522510:Intensity [Qualitative Concept]

Phrase: "is"

Phrase: "decreased in an AD case."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C0868928:Case [Functional Concept]
   760   C1706255:CASE [Medical Device]
   760   C1706256:Case [Conceptual Entity]
   726 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.79: (E,F) Control sections stained simultaneously following the same procedure, with the exception that the primary antibody was omitted. 

Phrase: "(E,F)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "simultaneously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521115:simultaneously [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the same procedure,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "with the exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1554961:exception [Idea or Concept]
  1000   C1705847:Exception [Conceptual Entity]

Phrase: "that"

Phrase: "the primary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "omitted."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750563:omitted [Idea or Concept]
Processing 00000000.tx.80: The lack of MT1 immunoreactivity confirms the specificity of the reaction. 

Phrase: "The lack of MT1 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332268:lack [Qualitative Concept]

Phrase: "confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the specificity of the reaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]
Processing 00000000.tx.81: Original magnification x242. 

Phrase: "Original magnification x242."
Processing 00000000.tx.82: The two AD cases showed the following differences in the distribution of MT1 immunoreactivity. 

Phrase: "The two AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the following differences in the distribution of MT1 immunoreactivity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   706   C1705241:*Difference [Quantitative Concept]
   706   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.83: First, the staining intensity and the numbers of MT1-immunoreactive cells were distinctly increased in ganglion cells and inner plexiform cell layers (Fig 1C). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the staining intensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522510:Intensity [Qualitative Concept]

Phrase: "and"

Phrase: "the numbers of MT1-immunoreactive cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0007584:Cell Number [Laboratory Procedure]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "were"

Phrase: "distinctly"

Phrase: "increased in ganglion cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0228071:Ganglion Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "inner plexiform cell layers"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   912   C1512785:Inner Plexiform Layer [Body Part, Organ, or Organ Component]
   812   C0934502:layers [Body Part, Organ, or Organ Component]
   779 E C1522408:Layer [Qualitative Concept]
   779 E C1561599:Layer [Intellectual Product]

Phrase: "(Fig 1C"

Phrase: ")."
Processing 00000000.tx.84: Second, both AD cases revealed well-stained amacrine cells, and the number of these MT1-immunoreactive cells was twice that in controls (Fig 1C). 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "both AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "well-stained amacrine cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0229216:Amacrine Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the number of these MT1-immunoreactive cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   750   C0007584:Cell Number [Laboratory Procedure]
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]

Phrase: "was"

Phrase: "twice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720725:Twice [Intellectual Product]
  1000   C1948050:Twice [Quantitative Concept]

Phrase: "that in controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "(Fig 1C"

Phrase: ")."
Processing 00000000.tx.85: There was also increased staining intensity within the inner plexiform layer. 

Phrase: "There"

Phrase: "was"

Phrase: "also"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "staining intensity within the inner plexiform layer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0522510:Intensity [Qualitative Concept]
Processing 00000000.tx.86: A decreased MT1 staining in the highly degenerated photoreceptor cell layer could be observed (Fig 1D). 

Phrase: "A decreased MT1 staining in the highly degenerated photoreceptor cell layer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0487602:Staining [Laboratory Procedure]
   736   C1704680:Staining [Finding]

Phrase: "could"

Phrase: "be"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416886:1D [Gene or Genome]
  1000   C1442449:1D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.87: Therefore, in AD cases only single cells were immunoreactive for MT1 so that there was no continuous band of immunoreactivity throughout the entire photoreceptor cell layer as in controls (Fig 1B and Fig D). 

Phrase: "Therefore,"

Phrase: "in AD cases only single cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "immunoreactive for MT1"

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that there"

Phrase: "was"

Phrase: "no continuous band of immunoreactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0175723:Band [Medical Device]
   760   C0439645:Band [Spatial Concept]
   760   C1521913:band [Cell Component]

Phrase: "throughout the entire photoreceptor cell layer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0934502:Layer [Body Part, Organ, or Organ Component]
   812   C1522408:Layer [Qualitative Concept]
   812   C1561599:Layer [Intellectual Product]
   708   C1269647:Entire cell [Cell]

Phrase: "as in controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "(Fig 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "and"

Phrase: "Fig"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "D)."
Processing 00000000.tx.88: Ocular Vessels In all control eyes a distinctly positive MT1 immunoreactivity in the adventitia of central retinal arteries and veins could be observed (Fig 2A and Fig 2B). 

Phrase: "Ocular Vessels In all control eyes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0005847:Vessels [Body Part, Organ, or Organ Component]
   719 E C1511228:Vessel [Tissue]

Phrase: "a distinctly positive MT1 immunoreactivity in the adventitia of central retinal arteries"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   735   C0597879:immunoreactivity [Molecular Function]

Phrase: "and"

Phrase: "veins"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042449:Veins [Body Part, Organ, or Organ Component]
   966 E C1278960:Vein [Body Part, Organ, or Organ Component]

Phrase: "could"

Phrase: "be"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig 2A"

Phrase: "and"

Phrase: "Fig 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.89: The same staining pattern was found even in the small retinal vessels located in the ganglion cell layer and inner plexiform layer (Fig 2E). 

Phrase: "The same staining pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449774:Pattern [Spatial Concept]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "even in the small retinal vessels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0035330:Retinal Vessels [Body Part, Organ, or Organ Component]
   783   C0225988:Small vessels, NOS [Body Part, Organ, or Organ Component]
   783   C1282841:Small vessels [Body Part, Organ, or Organ Component]
   753   C0005847:Vessels [Body Part, Organ, or Organ Component]
   753   C0035298:Retinal [Body Part, Organ, or Organ Component]
   753   C0700321:Small [Quantitative Concept]
   719 E C1511228:Vessel [Tissue]

Phrase: "located in the ganglion cell layer"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0229218:Ganglion cell layer [Body Part, Organ, or Organ Component]
   790   C0228071:Ganglion cell [Cell]
   753   C0007634:Cell [Cell]
   753   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   753   C0934502:Layer [Body Part, Organ, or Organ Component]
   753   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   753   C1269647:Cell [Cell]
   753   C1522408:Layer [Qualitative Concept]
   753   C1561599:Layer [Intellectual Product]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   748   C1517447:Ganglionic Layer [Tissue]

Phrase: "and"

Phrase: "inner plexiform layer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1512785:Inner Plexiform Layer [Body Part, Organ, or Organ Component]
   827   C0205102:Inner [Spatial Concept]
   827   C0450207:Plexiform [Spatial Concept]
   827   C0934502:Layer [Body Part, Organ, or Organ Component]
   827   C1522408:Layer [Qualitative Concept]
   827   C1561599:Layer [Intellectual Product]

Phrase: "(Fig 2E"

Phrase: ")."
Processing 00000000.tx.90: Both ciliary and choroidal vessels were devoid of MT1 immunoreactivity (Fig 2F). 

Phrase: "Both ciliary"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   944   C0015422:Eyelash [Body Part, Organ, or Organ Component]
   944   C1288305:Eyelash [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "choroidal vessels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0005847:Vessels [Body Part, Organ, or Organ Component]
   827 E C1511228:Vessel [Tissue]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "devoid of MT1 immunoreactivity"

Phrase: "(Fig 2F"

Phrase: ")."
Processing 00000000.tx.91: In AD, increased MT1 staining was detected in central arteries and veins and in retinal vessels, whereas ciliary and choroidal vessels were not stained (Fig 2D and Fig 2E). 

Phrase: "In AD,"

Phrase: "increased MT1 staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0487602:Staining [Laboratory Procedure]
   812   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "detected in central arteries"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C1516384:Central Artery [Body Part, Organ, or Organ Component]
   770   C0003842:Arteries [Body Part, Organ, or Organ Component]
   770   C0205099:Central [Spatial Concept]
   770   C0226004:arteries [Body System]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1879652:Central - [Laboratory Procedure]

Phrase: "and"

Phrase: "veins"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042449:Veins [Body Part, Organ, or Organ Component]
   966 E C1278960:Vein [Body Part, Organ, or Organ Component]

Phrase: "and in retinal vessels,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0035330:Retinal Vessels [Body Part, Organ, or Organ Component]
   770   C0005847:Vessels [Body Part, Organ, or Organ Component]
   770   C0035298:Retinal [Body Part, Organ, or Organ Component]
   770   C1515981:And [Idea or Concept]
   737 E C1511228:Vessel [Tissue]

Phrase: "whereas"

Phrase: "ciliary"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   944   C0015422:Eyelash [Body Part, Organ, or Organ Component]
   944   C1288305:Eyelash [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "choroidal vessels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0005847:Vessels [Body Part, Organ, or Organ Component]
   827 E C1511228:Vessel [Tissue]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Fig"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705052:2D [Spatial Concept]
  1000   C2986796:2D [Functional Concept]

Phrase: "and"

Phrase: "Fig 2E"

Phrase: ")."
Processing 00000000.tx.92: View larger version (158K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(158K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.93: The vessels of the retina. 

Phrase: "The vessels of the retina."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C1305222:Vessel of retina [Body Part, Organ, or Organ Component]
   797   C0035330:retina vessels [Body Part, Organ, or Organ Component]
   760   C0005847:Vessels [Body Part, Organ, or Organ Component]
   726 E C1511228:Vessel [Tissue]
Processing 00000000.tx.94: (A) The central arteria and (B) vein of controls display MT1 immunoreactivity as a red deposit. 

Phrase: "(A)"

Phrase: "The central arteria"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   950   C1516384:Central Artery [Body Part, Organ, or Organ Component]
   861   C0003842:Arteria [Body Part, Organ, or Organ Component]
   789 E C0221464:Arterial [Spatial Concept]
   761 E C0226004:arteries [Body System]

Phrase: "and ("

Phrase: "B) vein of controls"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0042449:Vein [Body Part, Organ, or Organ Component]
   770   C1278960:Vein [Body Part, Organ, or Organ Component]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "MT1 immunoreactivity as a red deposit."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597879:immunoreactivity [Molecular Function]
Processing 00000000.tx.95: (C) The control section (adjacent to A) omitting the primary antibody reveals no MT1 immunoreactivity. 

Phrase: "(C"

Phrase: ")"

Phrase: "The control section"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205155:Section [Spatial Concept]
   861   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   861   C1522472:Section [Substance]
   861   C1552923:Section [Quantitative Concept]
   861   C1705191:Section [Physical Object]

Phrase: "(adjacent to A)"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0205117:Adjacent to [Spatial Concept]
           Adjacent
   718 E C3242705:adjacency [Idea or Concept]

Phrase: "omitting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750563:omitting [Idea or Concept]

Phrase: "the primary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "no MT1 immunoreactivity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597879:immunoreactivity [Molecular Function]
Processing 00000000.tx.96: (D) The intensity of the vascular MT1 staining is distinctly increased in AD. 

Phrase: "("

Phrase: "D)"

Phrase: "The intensity of the vascular MT1 staining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0522510:Intensity [Qualitative Concept]

Phrase: "is"

Phrase: "distinctly"

Phrase: "increased in AD."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.97: (E) Retinal arteries are also immunopositive for MT1 as indicated by arrow (an AD case). 

Phrase: "(E) Retinal arteries"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0035301:Retinal Arteries [Body Part, Organ, or Organ Component]
   867 E C1280945:Retinal artery [Body Part, Organ, or Organ Component]
   827   C0003842:Arteries [Body Part, Organ, or Organ Component]
   827   C0035298:Retinal [Body Part, Organ, or Organ Component]
   827   C0226004:arteries [Body System]
   743 E C0221464:Arterial [Spatial Concept]

Phrase: "are"

Phrase: "also immunopositive for MT1"

Phrase: "as"

Phrase: "indicated by arrow"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0336721:Arrow [Manufactured Object]
   790   C1444656:Indicated [Finding]

Phrase: "("

Phrase: "an AD case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0868928:Case [Functional Concept]
   861   C1706255:CASE [Medical Device]
   861   C1706256:Case [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.98: (F) The choroidal vessels show no MT1 immunoreactivity (an AD case). 

Phrase: "(F)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "The choroidal vessels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0005847:Vessels [Body Part, Organ, or Organ Component]
   827 E C1511228:Vessel [Tissue]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "no MT1 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597879:immunoreactivity [Molecular Function]

Phrase: "("

Phrase: "an AD case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0868928:Case [Functional Concept]
   861   C1706255:CASE [Medical Device]
   861   C1706256:Case [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.99: GCL, ganglion cell layer; 

Phrase: "GCL,"

Phrase: "ganglion cell layer"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0229218:Ganglion cell layer [Body Part, Organ, or Organ Component]
   901   C0228071:Ganglion cell [Cell]
   877   C1517447:Ganglionic Layer [Tissue]
   827   C0007634:Cell [Cell]
   827   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   827   C0934502:Layer [Body Part, Organ, or Organ Component]
   827   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   827   C1269647:Cell [Cell]
   827   C1522408:Layer [Qualitative Concept]
   827   C1561599:Layer [Intellectual Product]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.100: IPL, inner plexiform layer; 

Phrase: "IPL,"

Phrase: "inner plexiform layer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1512785:Inner Plexiform Layer [Body Part, Organ, or Organ Component]
   827   C0205102:Inner [Spatial Concept]
   827   C0450207:Plexiform [Spatial Concept]
   827   C0934502:Layer [Body Part, Organ, or Organ Component]
   827   C1522408:Layer [Qualitative Concept]
   827   C1561599:Layer [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.101: INL, inner nucleiform layer; 

Phrase: "INL,"

Phrase: "inner nucleiform layer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0934502:Layer [Body Part, Organ, or Organ Component]
   827   C1522408:Layer [Qualitative Concept]
   827   C1561599:Layer [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.102: OPL, outer plexiform layer; 

Phrase: "OPL,"

Phrase: "outer plexiform layer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0229217:Outer Plexiform Layer [Body Part, Organ, or Organ Component]
   827   C0205101:Outer [Spatial Concept]
   827   C0450207:Plexiform [Spatial Concept]
   827   C0934502:Layer [Body Part, Organ, or Organ Component]
   827   C1522408:Layer [Qualitative Concept]
   827   C1561599:Layer [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.103: ONL, outer nucleiform layer; 

Phrase: "ONL,"

Phrase: "outer nucleiform layer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0934502:Layer [Body Part, Organ, or Organ Component]
   827   C1522408:Layer [Qualitative Concept]
   827   C1561599:Layer [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.104: g, ganglion cells; 

Phrase: "g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "ganglion cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0228071:Ganglion Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   861   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.105: a, amacrine cells. 

Phrase: "a,"

Phrase: "amacrine cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0229216:Amacrine Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.106: Original magnification x242. 

Phrase: "Original magnification x242."
Processing 00000000.tx.107: Discussion Top Summary Introduction Materials and Methods Results Discussion Literature Cited The present study has demonstrated the localization of MT1 in cellular structures of the retina and in ocular vessels of aged humans, and has provided preliminary evidence for alterations in retinal MT1 expresssion in AD patients. 

Phrase: "Discussion Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "demonstrated"

Phrase: "the localization of MT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "in cellular structures"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007634:Cellular structures [Cell]
  1000   C0243092:Cellular Structures [Cell Component]
   983 E C0935919:cellular structure [Qualitative Concept]
   861   C0678594:structures [Spatial Concept]

Phrase: "of the retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035298:Retina [Body Part, Organ, or Organ Component]
  1000   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "and in ocular vessels of aged humans,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   748   C0001779:Aged [Organism Attribute]
   748   C0001792:Aged [Population Group]
   748   C0005847:Vessels [Body Part, Organ, or Organ Component]
   748   C0015392:Ocular [Body Part, Organ, or Organ Component]
   748   C0042789:Ocular [Organism Function]
   748   C0086418:Humans [Human]
   748   C1299003:Ocular [Spatial Concept]
   748   C1515981:And [Idea or Concept]
   748   C1999167:aged [Population Group]
   714 E C1511228:Vessel [Tissue]

Phrase: "and"

Phrase: "has"

Phrase: "provided preliminary evidence for alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "in retinal MT1 expresssion"

Phrase: "in AD patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.108: After previous demonstration of melatonin, its synthesizing enzymes (Bubenik et al. 1974 ; Vivien-Roels et al. 1981 ; Wiechmann and Hollyfield 1989 ; Tosini 2000 ), and MT1 receptors in vertebrate retina (Fujieda et al. 1999 , Fujieda et al. 2000 ), this is the first demonstration of MT1 distribution in human retina. 

Phrase: "After previous demonstration"

Phrase: "of melatonin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025219:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
  1000   C1527137:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "its synthesizing enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]

Phrase: "(Bubenik et al. 1974"

Phrase: "; Vivien-Roels et al. 1981"

Phrase: "; Wiechmann"

Phrase: "and"

Phrase: "Hollyfield 1989"

Phrase: "; Tosini 2000"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "MT1 receptors in vertebrate retina"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   803   C1417449:MELATONIN RECEPTOR 1A [Gene or Genome]
   783   C0065911:Melatonin Receptors [Amino Acid, Peptide, or Protein,Receptor]
   753   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(Fujieda et al. 1999 ,"

Phrase: "Fujieda et al. 2000"

Phrase: ")"

Phrase: ","

Phrase: "this"

Phrase: "is"

Phrase: "the first demonstration of MT1 distribution"

Phrase: "in human retina."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035298:Retina [Body Part, Organ, or Organ Component]
   861   C1278894:Retina [Body Part, Organ, or Organ Component]
Processing 00000000.tx.109: Several types of retinal cells displayed MT1 immunoreactivity. 

Phrase: "Several types of retinal cells"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   822   C0449475:Type of cell [Intellectual Product]
           cells types
   764 E C0007634:Cell Type [Cell]
   760   C0332307:Types [Qualitative Concept]
   726 E C1547052:*Type [Quantitative Concept]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "MT1 immunoreactivity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597879:immunoreactivity [Molecular Function]
Processing 00000000.tx.110: The localization of MT1 to ganglion and amacrine cells is in accordance with previous reports in rodent retina (Fujieda et al. 1999 , Fujieda et al. 2000 ), where these cells are believed to be major sites of melatonin action. 

Phrase: "The localization of MT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "to ganglion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017067:Ganglion [Body Part, Organ, or Organ Component]
  1000   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]

Phrase: "and"

Phrase: "amacrine cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0229216:Amacrine Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "is in accordance with previous reports"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0205156:Previous [Temporal Concept]
   753   C0684224:Reports [Intellectual Product]
   753   C0700287:reports [Health Care Activity]
   753   C1552607:previous [Temporal Concept]
   719 E C3273238:Report [Intellectual Product]

Phrase: "in rodent retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035298:Retina [Body Part, Organ, or Organ Component]
   861   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "(Fujieda et al. 1999 ,"

Phrase: "Fujieda et al. 2000"

Phrase: ")"

Phrase: ","

Phrase: "where"

Phrase: "these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "major sites of melatonin action."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   797   C0581718:action sites [Intellectual Product]
   790   C2945843:Site of [Qualitative Concept]
   760   C0205145:Sites [Spatial Concept]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.111: Because MT1-positive amacrine cells have been found to be dopaminergic and GABAergic by double-immunolabeling experiments, a direct regulatory action of melatonin on dopamine release by enhancing GABA activity has been postulated (Fujieda et al. 2000 ). 

Phrase: "Because"

Phrase: "MT1-positive amacrine cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   853   C0439178:% positive cells [Quantitative Concept]
   840   C0229216:Amacrine Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "dopaminergic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282151:Dopaminergic [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "GABAergic by double-immunolabeling experiments,"

Phrase: "a direct regulatory action of melatonin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441472:Action [Functional Concept]
   753   C3266814:Action [Activity]

Phrase: "on dopamine release"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "by enhancing GABA activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "has"

Phrase: "been"

Phrase: "postulated"

Phrase: "(Fujieda et al. 2000"

Phrase: ")."
Processing 00000000.tx.112: Also in agreement with rodent studies, the strongly positive MT1 staining in the inner plexiform layer has been suggested to correspond to melatonin binding sites on dendritic processes of amacrine and ganglion cells (Fujieda et al. 1999 , Fujieda et al. 2000 ). 

Phrase: "Also in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with rodent studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "the strongly positive MT1 staining in the inner plexiform layer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0487602:Staining [Laboratory Procedure]
   738   C1704680:Staining [Finding]

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "correspond to melatonin binding sites"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0005456:Binding Sites [Receptor]
   773 E C0682969:Binding Site [Amino Acid Sequence]
   760   C0025219:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0205145:Sites [Spatial Concept]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1527137:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "on dendritic processes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0011305:Dendritic [Cell Component]
   861   C0439640:Dendritic [Qualitative Concept]
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "of amacrine"

Phrase: "and"

Phrase: "ganglion cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0228071:Ganglion Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   861   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fujieda et al. 1999 ,"

Phrase: "Fujieda et al. 2000"

Phrase: ")."
Processing 00000000.tx.113: In our series, no MT1 expression was detected in the outer plexiform layer or in the horizontal cells, similar to that in ganglion and amacrine cells. 

Phrase: "In our series,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205549:Series [Quantitative Concept]
  1000   C2348044:Series [Intellectual Product]

Phrase: "no MT1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "detected in the outer plexiform layer"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0229217:Outer Plexiform Layer [Body Part, Organ, or Organ Component]
   753   C0205101:Outer [Spatial Concept]
   753   C0442726:Detected [Finding]
   753   C0450207:Plexiform [Spatial Concept]
   753   C0934502:Layer [Body Part, Organ, or Organ Component]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1522408:Layer [Qualitative Concept]
   753   C1561599:Layer [Intellectual Product]

Phrase: "or in the horizontal cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   773   C0596713:horizontal cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0205126:Horizontal [Spatial Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "in ganglion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017067:Ganglion [Body Part, Organ, or Organ Component]
  1000   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]

Phrase: "and"

Phrase: "amacrine cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0229216:Amacrine Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.114: This contrasts to the strongly MT1-positive staining in the outer plexiform layer and horizontal cells in rat retina (Fujieda et al. 1999 ), which may reflect either interspecies differences or tissue-specific features. 

Phrase: "This contrasts to the strongly MT1-positive staining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1979874:Contrast [Qualitative Concept]

Phrase: "in the outer plexiform layer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0229217:Outer Plexiform Layer [Body Part, Organ, or Organ Component]
   827   C0205101:Outer [Spatial Concept]
   827   C0450207:Plexiform [Spatial Concept]
   827   C0934502:Layer [Body Part, Organ, or Organ Component]
   827   C1522408:Layer [Qualitative Concept]
   827   C1561599:Layer [Intellectual Product]

Phrase: "and"

Phrase: "horizontal cells in rat retina"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   844   C0229215:Retina, horizontal cells [Cell]
   808 E C1565000:Retinal Horizontal Cells [Cell]
   773   C0596713:horizontal cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0205126:Horizontal [Spatial Concept]
   760   C3282337:Cells [Cell]
   745   C2338017:Retinal cell [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(Fujieda et al. 1999"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "may"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "either interspecies differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1705241:*Difference [Quantitative Concept]
   793   C1705242:Difference [Qualitative Concept]
   743 E C0443199:Differential [Qualitative Concept]

Phrase: "or"

Phrase: "tissue-specific features."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C1521970:Feature [Qualitative Concept]
   793   C1706388:Feature [Conceptual Entity]
   793   C2346469:Feature [Qualitative Concept]
   793   C2348519:Feature [Qualitative Concept]
   734   C1955394:Tissue specific [Body Substance]
Processing 00000000.tx.115: Another contrast to rodents (Fujieda et al. 1999 , Fujieda et al. 2000 ) was the distinct MT1 staining in the inner segments of photoreceptor cells in elderly humans. 

Phrase: "Another contrast to rodents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1979874:Contrast [Qualitative Concept]

Phrase: "(Fujieda et al. 1999 ,"

Phrase: "Fujieda et al. 2000"

Phrase: ")"

Phrase: "was"

Phrase: "the distinct MT1 staining in the inner segments of photoreceptor cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0487602:Staining [Laboratory Procedure]
   736   C1704680:Staining [Finding]

Phrase: "in elderly humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086418:Humans [Human]
Processing 00000000.tx.116: Melatonin activates disc shedding in rodent photoreceptor cells (White and Fisher 1989 ). 

Phrase: "Melatonin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025219:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
  1000   C1527137:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "disc shedding in rodent photoreceptor cells"

Phrase: "(White"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "and"

Phrase: "Fisher 1989"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325045:Fisher [Mammal]

Phrase: ")."
Processing 00000000.tx.117: Melatonin has been located in the inner segments of photoreceptor cells and reaches a peak level in outer segments at the end of the night, which may be related to melatonin's protective action counteracting light's toxic effects (Hsu and Molday 1994 ; Marchiafava and Longoni 1999 ). 

Phrase: "Melatonin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025219:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
  1000   C1527137:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "located in the inner segments of photoreceptor cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   858   C1512787:Inner Segment of the Photoreceptor Cell [Cell Component]
   776   C1523372:photoreceptor inner segment [Cell Component]
   770   C0031760:Photoreceptor Cells [Cell]
           Photoreceptor
   744   C0007634:Cells [Cell]
   744   C0205102:Inner [Spatial Concept]
   744   C3282337:Cells [Cell]
   734   C2332214:Cell segment [Cell Component]
   711   C0441635:Segment [Spatial Concept]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "reaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0596012:Reaches [Finding]
  1000   C2584321:Reach [Organism Function]

Phrase: "a peak level in outer segments"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0444505:Peak level [Quantitative Concept]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "at the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the night,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0240526:Night [Temporal Concept]

Phrase: "which"

Phrase: "may"

Phrase: "be"

Phrase: "related to melatonin's protective action"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0025219:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0439849:Related [Qualitative Concept]
   760   C0441472:Action [Functional Concept]
   760   C0445223:Related [Finding]
   760   C1527137:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   760   C3266814:Action [Activity]
   726 E C0163712:Relate [Organic Chemical]

Phrase: "counteracting"

Phrase: "light's toxic effects"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   913   C0872206:light effects [Biologic Function]
   867   C0600688:Toxic effect [Injury or Poisoning]
           toxic
   827   C1280500:effects [Qualitative Concept]
   827   C1407029:Toxic [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "(Hsu"

Phrase: "and"

Phrase: "Molday 1994"

Phrase: "; Marchiafava"

Phrase: "and"

Phrase: "Longoni 1999"

Phrase: ")."
Processing 00000000.tx.118: Therefore, melatonin may be essential for photoreceptor cells. 

Phrase: "Therefore,"

Phrase: "melatonin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025219:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
  1000   C1527137:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "essential for photoreceptor cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]
Processing 00000000.tx.119: Our results indicate that, at least in aged humans, external melatonin sources may also play an important role in the maintenance of photoreceptor cells. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that,"

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in aged humans,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086418:Humans [Human]

Phrase: "external melatonin sources"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0449416:sources [Finding]
   793 E C1705919:Source [Idea or Concept]

Phrase: "may"

Phrase: "also"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in the maintenance of photoreceptor cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.120: Although only two AD cases were investigated, the MT1 alterations were notable. 

Phrase: "Although"

Phrase: "only two AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0868928:Cases [Functional Concept]
   812   C1533148:Cases [Quantitative Concept]
   779 E C1706255:CASE [Medical Device]
   779 E C1706256:Case [Conceptual Entity]

Phrase: "were"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: ","

Phrase: "the MT1 alterations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C1372742:Melatonin Alteration [Physiologic Function]
   793   C1515926:Alteration [Idea or Concept]

Phrase: "were"

Phrase: "notable."
Processing 00000000.tx.121: The increase of MT1 immunoreactivity in ganglion and amacrine cells may indicate receptor upregulation, possibly as a regulative response to declining nocturnal melatonin levels in elderly subjects and in AD (Ferrari et al. 2000 ), as we have already found in hippocampal neurons of AD patients (Savaskan et al. in press ). 

Phrase: "The increase of MT1 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "in ganglion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017067:Ganglion [Body Part, Organ, or Organ Component]
  1000   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]

Phrase: "and"

Phrase: "amacrine cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0229216:Amacrine Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "indicate"

Phrase: "receptor upregulation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0949479:receptor upregulation [Cell Function,Molecular Function]
   861   C0041904:Up-Regulation [Cell Function,Molecular Function]
   861   C0162493:Up-Regulation [Genetic Function]

Phrase: "possibly as a regulative response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2362652:Possibly [Qualitative Concept]
   760   C2911692:Response [Mental Process]

Phrase: "to declining nocturnal melatonin levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "in elderly subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "and in AD (Ferrari et al. 2000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1515981:And [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "we"

Phrase: "have"

Phrase: "already"

Phrase: "found in hippocampal neurons of AD patients"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   748   C0027882:Neurons [Cell]
   748   C0030705:Patients [Patient or Disabled Group]
   748   C0150312:Found [Quantitative Concept]
   714 E C0243095:Find [Finding]

Phrase: "(Savaskan et al."

Phrase: "in press"

Phrase: ")."
Processing 00000000.tx.122: Previous data localizing MT1 to both dendrites and axons of ganglion cells raised the possibility that retinal melatonin may act on dendritic processes, whereas pineal melatonin may stimulate ganglion cell terminals in their target areas (Fujieda et al. 2000 ). 

Phrase: "Previous data localizing MT1 to both dendrites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0450344:1A [Intellectual Product]
   744   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "axons of ganglion cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0004461:Axons [Cell Component]

Phrase: "raised"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442818:Raised [Quantitative Concept]

Phrase: "the possibility"

Phrase: "that retinal melatonin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025219:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   861   C1527137:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "may"

Phrase: "act on dendritic processes,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0011305:Dendritic [Cell Component]
   770   C0079613:ACT [Therapeutic or Preventive Procedure]
   770   C0439640:Dendritic [Qualitative Concept]
   737   C1184743:Process [Body Part, Organ, or Organ Component]
   737   C1522240:Process [Phenomenon or Process]

Phrase: "whereas"

Phrase: "pineal melatonin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025219:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   861   C1527137:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "may"

Phrase: "stimulate"

Phrase: "ganglion cell terminals in their target areas"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1185750:Terminal ganglion [Body Location or Region]
   714   C0205088:Terminal [Temporal Concept]
   714   C1705314:Terminal [Manufactured Object]
   714   C1705315:Terminal [Spatial Concept]

Phrase: "(Fujieda et al. 2000"

Phrase: ")."
Processing 00000000.tx.123: Therefore, pineal melatonin's feedback to the SCN has been assumed to occur both directly and indirectly via ganglion cells. 

Phrase: "Therefore,"

Phrase: "pineal melatonin's feedback to the SCN"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0015744:Feedback [Phenomenon or Process]
   748   C2911691:Feedback [Mental Process]

Phrase: "has"

Phrase: "been"

Phrase: "assumed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3242379:Assumed [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "both directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "and"

Phrase: "indirectly via ganglion cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0228071:Ganglion Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   770   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.124: Ganglion cells may be influenced by both pineal and retinal melatonin (Fujieda et al. 2000 ). 

Phrase: "Ganglion cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0228071:Ganglion Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   861   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "be"

Phrase: "influenced by both pineal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0031939:Pineal [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "retinal melatonin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025219:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   861   C1527137:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "(Fujieda et al. 2000"

Phrase: ")."
Processing 00000000.tx.125: This emphasizes a role for melatonin in ganglion cells in modifying retinal sensitivity and thus contributing to entrainment of rhythms driven by the SCN (Fujieda et al. 2000 ). 

Phrase: "This"

Phrase: "emphasizes"

Phrase: "a role for melatonin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in ganglion cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0228071:Ganglion Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   861   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "in modifying retinal sensitivity"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   827   C0036667:Sensitivity [Quantitative Concept]
   827   C0312418:Sensitivity [Mental Process]
   827   C0427965:Sensitivity [Finding]
   827   C1511883:Sensitivity [Quantitative Concept]
   827   C1522640:Sensitivity [Qualitative Concept]
   827   C2346484:SENSITIVITY [Phenomenon or Process]
   827   C2349185:Sensitivity [Qualitative Concept]
   755 E C0332324:Sensitive [Functional Concept]
   755 E C1550474:sensitive [Idea or Concept]

Phrase: "and"

Phrase: "thus"

Phrase: "contributing to entrainment of rhythms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0871269:rhythms [Finding]
   760   C1880177:Contributing [Activity]
   726 E C1523018:rhythm [Physiologic Function]

Phrase: "driven by the SCN"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0038866:Suprachiasmatic Nucleus [Body Part, Organ, or Organ Component]
   806   C1289559:Suprachiasmatic nucleus [Body Location or Region]
   760   C0007610:Nucleus [Cell Component]
   726   C0013126:Drive [Mental Process]

Phrase: "(Fujieda et al. 2000"

Phrase: ")."
Processing 00000000.tx.126: Mice completely lacking photoreceptor cells showed unattenuated phase-shifting responses to light, suggesting that novel ocular photoreceptors, possibly in ganglion and amacrine cells, may be active in circadian regulation (Freedman et al. 1999 ; Lucas et al. 1999 ). 

Phrase: "Mice completely"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "photoreceptor cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0031760:Photoreceptor Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "unattenuated phase-shifting responses to light,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   822   C2945741:response to light [Organism Function]
           light response
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that novel ocular photoreceptors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031760:Photoreceptors [Cell]

Phrase: "possibly in ganglion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   790   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   790   C2362652:Possibly [Qualitative Concept]

Phrase: "and"

Phrase: "amacrine cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0229216:Amacrine Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "be"

Phrase: "active in circadian regulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205177:Active [Functional Concept]

Phrase: "(Freedman et al. 1999"

Phrase: "; Lucas et al. 1999"

Phrase: ")."
Processing 00000000.tx.127: MT1 upregulation in retinal cells in AD may be related to altered photic input to the SCN, which itself is diminished in function in AD (Swaab et al. 1985 ), thus additionally contributing to the enhanced incidence of circadian rhythm disturbances in these subjects. 

Phrase: "MT1 upregulation in retinal cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0041904:Up-Regulation [Cell Function,Molecular Function]
   753   C0162493:Up-Regulation [Genetic Function]

Phrase: "in AD"

Phrase: "may"

Phrase: "be"

Phrase: "related to altered photic input"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0392747:Altered [Functional Concept]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C1708517:Input [Conceptual Entity]
   726 E C0163712:Relate [Organic Chemical]
   704   C0023693:Light [Natural Phenomenon or Process]
   704   C1306462:Light [Functional Concept]
   704   C1881376:Light [Qualitative Concept]

Phrase: "to the SCN,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038866:Suprachiasmatic Nucleus [Body Part, Organ, or Organ Component]
  1000   C1289559:Suprachiasmatic nucleus [Body Location or Region]
   861   C0007610:Nucleus [Cell Component]

Phrase: "which"

Phrase: "itself"

Phrase: "is"

Phrase: "diminished in function"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0031843:function [Physiologic Function]
   790   C0205216:Diminished [Quantitative Concept]
   790   C0542341:Function [Functional Concept]
   790   C0700205:FUNCTION [Classification]
   790   C1705273:Function [Intellectual Product]
   718 E C0205245:Functional [Functional Concept]
   718 E C2700217:Functional [Conceptual Entity]

Phrase: "in AD (Swaab et al. 1985"

Phrase: ")"

Phrase: ","

Phrase: "thus additionally"

Phrase: "contributing to the enhanced incidence of circadian rhythm disturbances"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0008810:Circadian Rhythm [Organism Function]
   764   C1522723:Circadian Rhythm [Biologic Function]
   742   C0021149:Incidence [Quantitative Concept]
   742   C0220856:incidence [Functional Concept]
   742   C0871269:Rhythm [Finding]
   742   C1523018:rhythm [Physiologic Function]
   742   C1880177:Contributing [Activity]
   742   C2349975:Enhanced [Activity]
   708   C2699787:Disturbance [Qualitative Concept]

Phrase: "in these subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]
Processing 00000000.tx.128: Free radicals are generated in mitochondria owing to their high respiratory activity (Demontis et al. 1997 ) and by light absorption (Reme et al. 1996 ). 

Phrase: "Free radicals"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   861   C0302912:radicals [Chemical Viewed Structurally]
   861   C0332296:free [Functional Concept]
   861   C1880497:Free [Qualitative Concept]
   861   C1996904:Free [Qualitative Concept]
   827 E C0439807:Radical [Qualitative Concept]

Phrase: "are"

Phrase: "generated in mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C3146294:Generated [Activity]

Phrase: "owing to their high respiratory activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "(Demontis et al. 1997"

Phrase: ")"

Phrase: "and by light absorption"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0234682:Light absorption [Cell Function]
   770   C0000854:Absorption [Natural Phenomenon or Process]
   770   C0023693:Light [Natural Phenomenon or Process]
   770   C0220777:absorption [Functional Concept]
   770   C1306462:Light [Functional Concept]
   770   C1515981:And [Idea or Concept]
   770   C1881376:Light [Qualitative Concept]
   770   C2347023:Absorption [Phenomenon or Process]
   770   C2347080:Absorption [Phenomenon or Process]
   770   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   770   C2825050:Absorption [Phenomenon or Process]

Phrase: "(Reme et al. 1996"

Phrase: ")."
Processing 00000000.tx.129: Melatonin, as a highly effective antioxidant scavenging free radicals, may therefore be essential for photoreceptor cells that are prone to generation of reactive oxygen species (Marchiafava and Longoni 1999 ). 

Phrase: "Melatonin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025219:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
  1000   C1527137:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "as"

Phrase: "a highly effective antioxidant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003402:Antioxidant [Pharmacologic Substance]

Phrase: "scavenging"

Phrase: "free radicals,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   861   C0302912:radicals [Chemical Viewed Structurally]
   861   C0332296:free [Functional Concept]
   861   C1880497:Free [Qualitative Concept]
   861   C1996904:Free [Qualitative Concept]
   827 E C0439807:Radical [Qualitative Concept]

Phrase: "may"

Phrase: "therefore"

Phrase: "be"

Phrase: "essential for photoreceptor cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "prone to generation of reactive oxygen species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033422:Prone [Spatial Concept]

Phrase: "(Marchiafava"

Phrase: "and"

Phrase: "Longoni 1999"

Phrase: ")."
Processing 00000000.tx.130: On the other hand, there is contrary evidence about the protective role of melatonin within the retina. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "there"

Phrase: "is"

Phrase: "contrary evidence about the protective role of melatonin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "within the retina."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035298:Retina [Body Part, Organ, or Organ Component]
  1000   C1278894:Retina [Body Part, Organ, or Organ Component]
Processing 00000000.tx.131: Systemic administration of melatonin increases retinal light damage and the melatonin receptor competitive antagonist luzindole protects photoreceptor cells from light damage (Sugawara et al. 1998 ). 

Phrase: "Systemic administration of melatonin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0678812:systemic administration [Therapeutic or Preventive Procedure]
   770   C0001554:Administration [Occupational Activity]
   770   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "retinal light damage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0235272:Retinal damage [Disease or Syndrome]
   827   C0010957:Damage [Injury or Poisoning]
   827   C1883709:Damage [Functional Concept]

Phrase: "and"

Phrase: "the melatonin receptor competitive antagonist luzindole"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0065275:luzindole [Organic Chemical]

Phrase: "protects"

Phrase: "photoreceptor cells from light damage"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C0031760:Photoreceptor Cells [Cell]
   797   C0599732:cells damage [Cell or Molecular Dysfunction]
   781   C1517881:Light Cell [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(Sugawara et al. 1998"

Phrase: ")."
Processing 00000000.tx.132: Melatonin's modulatory action on dopaminergic transmission has been postulated to regulate susceptibility to light damage (Iuvone and Gan 1995 ; Sugawara et al. 1998 ). 

Phrase: "Melatonin's modulatory action on dopaminergic transmission"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441472:Action [Functional Concept]
   753   C3266814:Action [Activity]

Phrase: "has"

Phrase: "been"

Phrase: "postulated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "regulate"

Phrase: "susceptibility to light damage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "(Iuvone"

Phrase: "and"

Phrase: "Gan 1995"

Phrase: "; Sugawara et al. 1998"

Phrase: ")."
Processing 00000000.tx.133: Therefore, the decrease in MT1 immunoreactivity in photoreceptor cells in AD may be related to the marked degenerative changes found in these cells. 

Phrase: "Therefore,"

Phrase: "the decrease in MT1 immunoreactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "in photoreceptor cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0031760:Photoreceptor Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "in AD"

Phrase: "may"

Phrase: "be"

Phrase: "related to the marked degenerative changes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   756   C0011164:Degenerative change [Pathologic Function]
           Degenerative
   753   C0392747:changes [Functional Concept]
   753   C0439849:Related [Qualitative Concept]
   753   C0443172:changes [Quantitative Concept]
   753   C0445223:Related [Finding]
   753   C0522501:Marked [Qualitative Concept]
   753   C1706089:Marked [Qualitative Concept]
   753   C1880269:Degenerative [Functional Concept]
   719 E C0163712:Relate [Organic Chemical]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "found in these cells."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0150312:Found [Quantitative Concept]
   770   C3282337:Cells [Cell]
   737 E C0243095:Find [Finding]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.134: In addition to cellular structures, central and retinal vessels were also immunoreactive for MT1 in their adventitia. 

Phrase: "In addition to cellular structures,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007634:Cellular structures [Cell]
  1000   C0243092:Cellular Structures [Cell Component]
   983 E C0935919:cellular structure [Qualitative Concept]
   861   C0678594:structures [Spatial Concept]

Phrase: "central"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205099:Central [Spatial Concept]
  1000   C1879652:Central - [Laboratory Procedure]

Phrase: "and"

Phrase: "retinal vessels"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0035330:Retinal Vessels [Body Part, Organ, or Organ Component]
   861   C0005847:Vessels [Body Part, Organ, or Organ Component]
   827 E C1511228:Vessel [Tissue]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "also immunoreactive for MT1"

Phrase: "in their adventitia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0225342:Adventitia [Tissue]
Processing 00000000.tx.135: Melatonin is a potent vasoactive substance regulating cerebrovascular responsiveness and blood flow in brain (Regriny et al. 1998 ). 

Phrase: "Melatonin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025219:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
  1000   C1527137:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "is"

Phrase: "a potent vasoactive substance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439861:Substance [Substance]

Phrase: "regulating"

Phrase: "cerebrovascular responsiveness"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   789   C0205342:Responsive [Functional Concept]
   761 E C2371924:Responsivity [Mental Process]

Phrase: "and"

Phrase: "blood flow in brain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0232338:Blood flow [Organism Function]
   770   C0005767:Blood [Tissue]
   770   C0005768:blood [Body Substance]
   770   C0229664:Blood [Body Substance]
   770   C0806140:Flow [Natural Phenomenon or Process]

Phrase: "(Regriny et al. 1998"

Phrase: ")."
Processing 00000000.tx.136: Melatonin administration induces cerebral vasoconstriction, resulting in improved dilatory capacity (Regriny et al. 1998 ). 

Phrase: "Melatonin administration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001554:Administration [Occupational Activity]
   861   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "cerebral vasoconstriction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042396:Vasoconstriction [Organ or Tissue Function]
   861   C3536904:Vasoconstriction [Organ or Tissue Function]

Phrase: "resulting in improved dilatory capacity"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0332294:Resulting in [Functional Concept]
   760   C0184511:Improved [Qualitative Concept]
   760   C0332272:Improved [Qualitative Concept]
   760   C0678226:resulting [Functional Concept]
   760   C1516240:Capacity [Quantitative Concept]
   760   C1561611:Improved [Intellectual Product]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "(Regriny et al. 1998"

Phrase: ")."
Processing 00000000.tx.137: The vascularization of the retina arises from two different sources, both originating from the arteria ophthalmica. 

Phrase: "The vascularization of the retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0027686:Vascularisation [Pathologic Function]
   760   C0042382:Vascularisation [Functional Concept]

Phrase: "arises from two different sources,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0205448:Two [Quantitative Concept]
   760   C0449416:sources [Finding]
   760   C1705242:Different [Qualitative Concept]
   726 E C1705919:Source [Idea or Concept]

Phrase: "both originating from the arteria ophthalmica."
Processing 00000000.tx.138: Whereas the arteria centralis retinae supplies the inner layers, including ganglion cell and inner plexiform layers, ciliary and choroidal vessels are responsible for blood circulation in outer layers (Spencer 1996 ). 

Phrase: "Whereas"

Phrase: "the arteria centralis retinae"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035301:Arteria centralis retinae [Body Part, Organ, or Organ Component]
   793   C0035298:Retina [Body Part, Organ, or Organ Component]
   793   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "supplies"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0038848:Supplies [Manufactured Object]
  1000   C0243163:supply [Idea or Concept]
  1000   C0699914:supply [Quantitative Concept]
  1000   C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
  1000   C1561604:supply [Functional Concept]
  1000   C1875802:SUPPLY [Medical Device]
  1000   C1999230:Supply [Activity]

Phrase: "the inner layers,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0934502:layers [Body Part, Organ, or Organ Component]
   827 E C1522408:Layer [Qualitative Concept]
   827 E C1561599:Layer [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "ganglion cell"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0228071:Ganglion cell [Cell]
   861   C0007634:Cell [Cell]
   861   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   861   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "inner plexiform layers,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   966   C1512785:Inner Plexiform Layer [Body Part, Organ, or Organ Component]
   827   C0205102:Inner [Spatial Concept]
   827   C0450207:Plexiform [Spatial Concept]
   827   C0934502:layers [Body Part, Organ, or Organ Component]
   793 E C1522408:Layer [Qualitative Concept]
   793 E C1561599:Layer [Intellectual Product]

Phrase: "ciliary"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   944   C0015422:Eyelash [Body Part, Organ, or Organ Component]
   944   C1288305:Eyelash [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "choroidal vessels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0005847:Vessels [Body Part, Organ, or Organ Component]
   827 E C1511228:Vessel [Tissue]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "are"

Phrase: "responsible for blood circulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "in outer layers"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0934502:layers [Body Part, Organ, or Organ Component]
   827 E C1522408:Layer [Qualitative Concept]
   827 E C1561599:Layer [Intellectual Product]

Phrase: "(Spencer 1996"

Phrase: ")."
Processing 00000000.tx.139: The localization of MT1 was distinctly restricted to the vascular network of the retinal vessel system. 

Phrase: "The localization of MT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "was"

Phrase: "distinctly"

Phrase: "restricted to the vascular network of the retinal vessel system."
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   760   C0005839:Vascular network [Body Part, Organ, or Organ Component]
   760   C0035330:Vessel, Retinal [Body Part, Organ, or Organ Component]
       E   Retinal blood vessel
           blood retinal vessels
   757   C0489903:Vascular System [Body System]
   757   C0549652:RETINAL VASCULAR [Pathologic Function]
   739   C0005847:Vessel [Body Part, Organ, or Organ Component]
           vascular
   739   C0035298:Retinal [Body Part, Organ, or Organ Component]
   739   C0443288:Restricted [Functional Concept]
   739   C0449913:System [Functional Concept]
   739   C1511228:Vessel [Tissue]
   739   C1513822:Network [Professional or Occupational Group]
   739   C1553451:System [Manufactured Object]
   739   C1558950:VASCULAR [Finding]
   739   C1704459:System [Medical Device]
   739   C1705739:Network [Manufactured Object]
   739   C1801960:Vascular [Qualitative Concept]
   739   C1882071:Network [Conceptual Entity]
   702 E C0242201:Hemic System [Body System]
Processing 00000000.tx.140: MT1 is localized to the vascular adventitia and not to the smooth muscle layer (Savaskan et al. 2001 ). 

Phrase: "MT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "is"

Phrase: "localized to the vascular adventitia"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0005847:vascular [Body Part, Organ, or Organ Component]
   760   C0225342:Adventitia [Tissue]
   760   C0392752:Localized [Spatial Concept]
   760   C1558950:VASCULAR [Finding]
   760   C1801960:Vascular [Qualitative Concept]
   704 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   704 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "and"

Phrase: "not to the smooth muscle layer"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0225358:Muscle layer [Tissue]
   790   C1267092:Muscle, Smooth [Tissue]
   753   C0026845:Muscle [Tissue]
   753   C0205357:Smooth [Qualitative Concept]
   753   C0934502:Layer [Body Part, Organ, or Organ Component]
   753   C1518422:Not [Functional Concept]
   753   C1522408:Layer [Qualitative Concept]
   753   C1561599:Layer [Intellectual Product]

Phrase: "(Savaskan et al. 2001"

Phrase: ")."
Processing 00000000.tx.141: The adventitial localization of MT1 suggests an indirect action of melatonin on smooth muscle of the vasculature. 

Phrase: "The adventitial localization of MT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "an indirect action of melatonin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441472:Action [Functional Concept]
   760   C3266814:Action [Activity]

Phrase: "on smooth muscle"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1267092:Muscle, Smooth [Tissue]
   861   C0026845:Muscle [Tissue]
   861   C0205357:Smooth [Qualitative Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "of the vasculature."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005839:vasculature [Body Part, Organ, or Organ Component]
Processing 00000000.tx.142: The upregulation of vascular MT1 expression in AD retina parallels our recent findings in cerebrovascular MT1 immunoreactivity (Savaskan et al. 2001 ). 

Phrase: "The upregulation of vascular MT1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0041904:Up-Regulation [Cell Function,Molecular Function]
   748   C0162493:Up-Regulation [Genetic Function]

Phrase: "in AD retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035298:Retina [Body Part, Organ, or Organ Component]
   861   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "parallels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2348042:Parallel [Qualitative Concept]
  1000   C2826345:PARALLEL [Research Activity]

Phrase: "our recent findings in cerebrovascular MT1 immunoreactivity"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   744   C2607943:findings [Functional Concept]
   744   C2926606:Findings [Clinical Attribute]
   744   C3539655:Findings [Intellectual Product]
   711 E C0037088:Finding [Sign or Symptom]
   711 E C0243095:Finding [Finding]
   711 E C2825141:Finding [Finding]

Phrase: "(Savaskan et al. 2001"

Phrase: ")."
Processing 00000000.tx.143: Cerebral hypoperfusion plays a decisive role in initiating neurodegeneration in AD (De la Torre and Stefano 2000 ). 

Phrase: "Cerebral hypoperfusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442856:Hypoperfusion [Functional Concept]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a decisive role in initiating neurodegeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in AD (De la Torre"

Phrase: "and"

Phrase: "Stefano 2000"

Phrase: ")."
Processing 00000000.tx.144: Therefore, the observed alterations in vascular MT1 expression in other brain regions in AD (Savaskan et al. 2001 ) may be accompanied by corresponding changes in retina. 

Phrase: "Therefore,"

Phrase: "the observed alterations in vascular MT1 expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C2267116:Vascular Alterations [Physiologic Function]
   750   C1372742:Melatonin Alteration [Physiologic Function]
   711   C1515926:Alteration [Idea or Concept]

Phrase: "in other brain regions"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C1273723:brain regions [Body Location or Region]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "in AD (Savaskan et al. 2001"

Phrase: ")"

Phrase: "may"

Phrase: "be"

Phrase: "accompanied by corresponding changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "in retina."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035298:Retina [Body Part, Organ, or Organ Component]
  1000   C1278894:Retina [Body Part, Organ, or Organ Component]
Processing 00000000.tx.145: Taken together, the results provide evidence that melatonin may be involved in different cellular and vascular processes in the human retina via MT1. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that melatonin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025219:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
  1000   C1527137:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "involved in different cellular"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0007634:Cellular [Cell]
   770   C0178539:Cellular [Functional Concept]
   770   C1314939:Involved [Functional Concept]
   770   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "vascular processes in the human retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1184743:Process [Body Part, Organ, or Organ Component]
   719   C1522240:Process [Phenomenon or Process]

Phrase: "via MT1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]
Processing 00000000.tx.146: The evaluation of a larger number of cases will be necessary to confirm the striking alterations in AD. 

Phrase: "The evaluation of a larger number of cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0220825:Evaluation [Functional Concept]
   744   C1261322:Evaluation [Health Care Activity]

Phrase: "will"

Phrase: "be"

Phrase: "necessary to"

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the striking alterations in AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1515926:Alteration [Idea or Concept]
Processing 00000000.tx.147: Understanding the effects of melatonin in retina as well as brain may be important to combat neurodegeneration and circadian disturbances in AD. 

Phrase: "Understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understanding [Mental Process]

Phrase: "the effects of melatonin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "in retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035298:Retina [Body Part, Organ, or Organ Component]
  1000   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "as well as"

Phrase: "brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "may"

Phrase: "be"

Phrase: "important to"

Phrase: "combat"

Phrase: "neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "circadian disturbances in AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2699787:Disturbance [Qualitative Concept]
Processing 00000000.tx.148: Acknowledgments Supported by grants from the CNRS, the Universit Paris VII, and the Association pour la Recherche sur le Cancer (ARC 5513) to LB and RJ. 

Phrase: "Acknowledgments"

Phrase: "Supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the CNRS,"

Phrase: "the Universit Paris VII,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0445385:VII [Intellectual Product]

Phrase: "and"

Phrase: "the Association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "pour"

Phrase: "la Recherche sur le Cancer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0006826:Cancer [Neoplastic Process]
   804   C0998265:Cancer [Eukaryote]
   804   C1306459:Cancer [Finding]

Phrase: "(ARC 5513"

Phrase: ")"

Phrase: "to LB"

Phrase: "and"

Phrase: "RJ."
Processing 00000000.tx.149: We thank Prof Ch. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Prof Ch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0558269:Ch. [Professional or Occupational Group]
   861   C1552984:[Ch] [Quantitative Concept]
Processing 00000000.tx.150: E. 

Phrase: "E."
Processing 00000000.tx.151: Rem (University of Zrich, Switzerland) for her invaluable advice. 

Phrase: "Rem (University of Zrich,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0041740:University [Manufactured Object,Organization]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: "for her invaluable advice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0150600:Advice [Health Care Activity]
Processing 00000000.tx.152: Received for publication August 21, 2001; 

Phrase: "Received for publication August 21,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2001"

Phrase: ";"
Processing 00000000.tx.153: accepted November 21, 2001. 

Phrase: "accepted November 21,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2001."
Processing 00000000.tx.154: Literature Cited Top Summary Introduction Materials and Methods Results Discussion Literature Cited Brydon L, Roka F, Petit L, De Coppet P, Tissot M, Barrett P, Morgan PJ, Nanoff C, Strosberg AD, Jockers R (1999) Dual signaling of human Mel1a melatonin receptors via Gi2, Gi3 and Gq/11 proteins. 

Phrase: "Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023866:Literature [Intellectual Product]
  1000   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "Brydon L,"

Phrase: "Roka F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Petit L,"

Phrase: "De Coppet P,"

Phrase: "Tissot M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Barrett P,"

Phrase: "Morgan PJ,"

Phrase: "Nanoff C,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "Strosberg AD,"

Phrase: "Jockers R (1999"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: "Dual signaling of human Mel1a melatonin receptors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1514762:Receptor Signaling [Molecular Function]
   748   C0037083:Signaling [Cell Function]
   748   C3537152:signaling [Biologic Function]

Phrase: "via Gi2,"

Phrase: "Gi3"

Phrase: "and"

Phrase: "Gq/11 proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0767337:Gq Protein [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.155: Mol Endocrinol 13:2025-2038[Abstract/Free FullText] Bubenik GA, Brown GM, Uhlir I, Grota LJ (1974) Immunohistological localization of N-acetylindolalkylamines in pineal gland, retina and cerebellum. 

Phrase: "Mol Endocrinol 13"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0027960:Mole [Neoplastic Process]
   827   C0324740:Mole [Mammal]
   827   C0439189:Mole [Quantitative Concept]
   827   C1456781:mole [Neoplastic Process]
   827   C1824986:mol [Gene or Genome]
   743 E C0026367:Molar [Body Part, Organ, or Organ Component]
   727 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "2025-2038"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bubenik GA,"

Phrase: "Brown GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Uhlir I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Grota LJ"

Phrase: "(1974"

Phrase: ")"

Phrase: "Immunohistological localization of N-acetylindolalkylamines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "in pineal gland,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0031939:Pineal gland [Body Part, Organ, or Organ Component]
           Pineal
  1000   C1278881:Pineal gland [Body Part, Organ, or Organ Component]
  1000   C1519088:GLAND, PINEAL [Tissue]
   861   C1285092:Gland [Body Part, Organ, or Organ Component]

Phrase: "retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035298:Retina [Body Part, Organ, or Organ Component]
  1000   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "cerebellum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]
Processing 00000000.tx.156: Brain Res 81:233-242[Medline] De la Torre JC, Stefano GB (2000) Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide. 

Phrase: "Brain Res 81"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "233-242"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] De la Torre JC,"

Phrase: "Stefano GB (2000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041700:GB [Geographic Area]
   827   C1551090:Gb [Quantitative Concept]

Phrase: ")"

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "a microvascular disorder"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012634:Disorder [Disease or Syndrome]

Phrase: ":"

Phrase: "the role of constitutive nitric oxide."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.157: Brain Res Rev 34:119-136[Medline] Demontis GC, Longoni B, Gargini C, Cervetto L (1997) The energetic cost of photoreception in retinal rods of mammals. 

Phrase: "Brain Res Rev 34"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C2347379:RES [Finding]
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "119-136"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Demontis GC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3537453:GC [Gene or Genome]

Phrase: "Longoni B,"

Phrase: "Gargini C,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "Cervetto L (1997"

Phrase: ")"

Phrase: "The energetic cost of photoreception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0010186:Cost [Quantitative Concept]
   760   C0220812:cost [Quantitative Concept]

Phrase: "in retinal rods"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   861   C0035298:Retinal [Body Part, Organ, or Organ Component]
   861   C0206427:Rods [Cell]
   827 E C1552915:rod [Quantitative Concept]
   827 E C1705186:Rod [Medical Device]
   827 E C1947942:Rod [Spatial Concept]
   827 E C2347970:rod [Quantitative Concept]
   827 E C2347971:rod [Quantitative Concept]

Phrase: "of mammals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024660:Mammals [Mammal]
Processing 00000000.tx.158: Arch Ital Biol 135:95-109[Medline] Dubocovich ML (1983) Melatonin is a potent modulator of dopamine release in the retina. 

Phrase: "Arch Ital Biol 135"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0230467:arch [Body Location or Region]
   812   C0741204:ARCH [Body Space or Junction]

Phrase: ":"

Phrase: "95-109"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dubocovich ML (1983"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: "Melatonin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025219:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
  1000   C1527137:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "is"

Phrase: "a potent modulator of dopamine release"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709060:Modulator [Manufactured Object]

Phrase: "in the retina."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035298:Retina [Body Part, Organ, or Organ Component]
  1000   C1278894:Retina [Body Part, Organ, or Organ Component]
Processing 00000000.tx.159: Nature 306:782-784[Medline] Dubocovich ML, Masana MI, Benloucif S (2000) Molecular pharmacology and function of melatonin receptor subtypes. 

Phrase: "Nature 306"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "782-784"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dubocovich ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Masana MI,"

Phrase: "Benloucif"

Phrase: "S ("

Phrase: "2000"

Phrase: ")"

Phrase: "Molecular pharmacology"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0031330:Pharmacology [Biomedical Occupation or Discipline]
   861   C1524059:pharmacology [Functional Concept]
   789 E C0205464:Pharmacologic [Functional Concept]

Phrase: "and"

Phrase: "function of melatonin receptor subtypes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0920644:function receptor [Molecular Function]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]
Processing 00000000.tx.160: In Olcese J, ed. 

Phrase: "In Olcese J,"

Phrase: "ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]
Processing 00000000.tx.161: Melatonin after Four Decades. 

Phrase: "Melatonin after Four Decades."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0025219:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   770   C1527137:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
Processing 00000000.tx.162: New York, Kluwer Academic/Plenum Publishers, 181-190 Ferrari E, Arcaini A, Gornati R, Pelanconi L, Cravello L, Fioravanti M, Solerte SB, Magri F (2000) Pineal and pituitary-adrenocortical function in physiological aging and in senile dementia. 

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "Kluwer Academic/Plenum Publishers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1709767:Publisher [Occupation or Discipline]

Phrase: "181-190 Ferrari E,"

Phrase: "Arcaini A,"

Phrase: "Gornati R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Pelanconi L,"

Phrase: "Cravello L,"

Phrase: "Fioravanti M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Solerte SB,"

Phrase: "Magri F (2000"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: ")"

Phrase: "Pineal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031939:Pineal [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "pituitary-adrenocortical function in physiological aging"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "and in senile dementia."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0002395:Dementia, Senile [Disease or Syndrome]
   833   C0011268:Senile dementia [Mental or Behavioral Dysfunction]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0392079:Senile [Finding]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]
   770   C1515981:And [Idea or Concept]
   715 E C0231337:Old age [Finding]
   715 E C1999167:Old age [Population Group]
Processing 00000000.tx.163: Exp Gerontol 35:1239-1250[Medline] Freedman MS, Lucas RJ, Soni B, Von Schantz M, Muoz M, DavidGray Z, Foster R (1999) Regulation of mammalian circadian behavior by non-rod, non-cone, ocular photoreceptors. 

Phrase: "Exp Gerontol 35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "1239-1250"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Freedman MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Lucas RJ,"

Phrase: "Soni B,"

Phrase: "Von Schantz M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Muoz M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "DavidGray Z,"

Phrase: "Foster R (1999"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205090:R- [Spatial Concept]
   827   C0242298:foster [Daily or Recreational Activity]
   827   C0344349:foster [Family Group]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: "Regulation of mammalian circadian behavior"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C1325858:regulation of behavior [Individual Behavior]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "by non-rod,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0206427:Rod [Cell]
   861   C1552915:rod [Quantitative Concept]
   861   C1705186:Rod [Medical Device]
   861   C1947942:Rod [Spatial Concept]
   861   C2347970:rod [Quantitative Concept]
   861   C2347971:rod [Quantitative Concept]

Phrase: "non-cone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0206428:Cone [Cell]
   861   C0330095:Cone [Plant]
   861   C2350017:Cone [Spatial Concept]

Phrase: "ocular photoreceptors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031760:Photoreceptors [Cell]
Processing 00000000.tx.164: Science 284:502-504[Abstract/Free FullText] Fujieda H, Hamadanizadeh SA, Wankiewicz E, Pang SF, Brown GM (1999) Expression of mt1 melatonin receptor in rat retina: evidence for multiple cell targets for melatonin. 

Phrase: "Science 284"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "502-504"

Phrase: "[Abstract/Free FullText"

Phrase: "] Fujieda H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hamadanizadeh SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Wankiewicz E,"

Phrase: "Pang"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413561:PANG [Gene or Genome]

Phrase: "SF,"

Phrase: "Brown GM (1999"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0546866:GM [Antibiotic,Carbohydrate]
   827   C0678579:Brown [Natural Phenomenon or Process]

Phrase: ")"

Phrase: "Expression of mt1 melatonin receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0597360:receptor expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in rat retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035298:Retina [Body Part, Organ, or Organ Component]
   861   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "evidence for multiple cell targets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "for melatonin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025219:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
  1000   C1527137:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
Processing 00000000.tx.165: Neuroscience 93:793-799[Medline] Fujieda H, Scher J, Hamadanizadeh SA, Wankiewicz E, Pang SF, Brown GM (2000) Dopaminergic and GABAergic amacrine cells are direct targets of melatonin: immunocytochemical study of mt1 melatonin receptor in guinea pig retina. 

Phrase: "Neuroscience 93"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: ":"

Phrase: "793-799"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fujieda H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Scher J,"

Phrase: "Hamadanizadeh SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Wankiewicz E,"

Phrase: "Pang"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413561:PANG [Gene or Genome]

Phrase: "SF,"

Phrase: "Brown GM (2000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0546866:GM [Antibiotic,Carbohydrate]
   827   C0678579:Brown [Natural Phenomenon or Process]

Phrase: ")"

Phrase: "Dopaminergic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282151:Dopaminergic [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "GABAergic amacrine cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0229216:Amacrine Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "direct targets of melatonin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   816   C1550500:direct target [Idea or Concept]
   737   C1521840:Target [Functional Concept]
   737   C2986546:TARGET [Diagnostic Procedure]

Phrase: ":"

Phrase: "immunocytochemical study of mt1 melatonin receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]

Phrase: "in guinea pig retina."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0035298:Retina [Body Part, Organ, or Organ Component]
   827   C1278894:Retina [Body Part, Organ, or Organ Component]
   734   C0085979:Guinea pig, NOS [Mammal]
   734   C0999699:Guinea-pig [Mammal]
Processing 00000000.tx.166: Vis Neurosci 17:63-70[Medline] Herzog ED, Block GD (1999) Keeping an eye on retinal clocks. 

Phrase: "Vis Neurosci 17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1571809:VIS [Therapeutic or Preventive Procedure]

Phrase: ":"

Phrase: "63-70"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Herzog ED,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]

Phrase: "Block GD (1999"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0028778:Block [Pathologic Function]
   827   C0332206:Block [Functional Concept]
   827   C1533157:Block [Substance]
   827   C1706084:Block [Geographic Area]
   827   C2828370:Block [Quantitative Concept]
   755 E C2983591:BLOCKED [Research Activity]

Phrase: ")"

Phrase: "Keeping"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0333118:Keep [Functional Concept]

Phrase: "an eye on retinal clocks."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0015392:Eye [Body Part, Organ, or Organ Component]
   760   C1280202:Eye [Body Part, Organ, or Organ Component]
   704 E C0029144:optic [Occupation or Discipline]
   704 E C0042789:Ocular [Organism Function]
   704 E C1299003:Ocular [Spatial Concept]
Processing 00000000.tx.167: Chronobiol Int 16:229-247[Medline] Hsu S-C, Molday RS (1994) Glucose metabolism in photoreceptor outer segments. 

Phrase: "Chronobiol Int 16"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0063789:INT [Organic Chemical]
   827   C3272375:INT [Intellectual Product]

Phrase: ":"

Phrase: "229-247"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hsu"

Phrase: "S-"

Phrase: "C,"

Phrase: "Molday RS (1994"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3539879:RS [Idea or Concept]

Phrase: ")"

Phrase: "Glucose metabolism in photoreceptor outer segments."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0596620:glucose metabolism [Molecular Function]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.168: J Biol Chem 269:17954-17959[Abstract/Free FullText] Iuvone PM, Gan J (1995) Functional interaction of melatonin receptors and D1 dopamine receptors in cultured chick retinal neurons. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "17954-17959"

Phrase: "[Abstract/Free FullText"

Phrase: "] Iuvone PM, Gan J (1995"

Phrase: ")"

Phrase: "Functional interaction of melatonin receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "D1 dopamine receptors in cultured chick retinal neurons."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   789   C0058697:Receptors, Dopamine D1 [Amino Acid, Peptide, or Protein,Receptor]
           D1 receptor
   776 E C1333250:DOPAMINE RECEPTOR D1 [Gene or Genome]
   776 E C1367800:Dopamine Receptor D1 [Amino Acid, Peptide, or Protein,Receptor]
   770   C0034798:Receptors, Dopamine [Amino Acid, Peptide, or Protein,Receptor]
   767   C1512035:dopamine neurons [Cell]
   744   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   744   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   709   C2325760:Neuronal receptor [Cell Component]
Processing 00000000.tx.169: J Neurosci 15:2179-2185[Abstract] Lucas RJ, Freedman MS, Muoz M, GarciaFernndez J-M, Foster RG (1999) Regulation of the mammalian pineal by non-rod, non-cone, ocular receptors. 

Phrase: "J Neurosci 15"

Phrase: ":"

Phrase: "2179-2185"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lucas RJ,"

Phrase: "Freedman MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Muoz M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "GarciaFernndez J-M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Foster RG (1999"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0242298:foster [Daily or Recreational Activity]
   827   C0344349:foster [Family Group]
   827   C1412999:RG [Gene or Genome]

Phrase: ")"

Phrase: "Regulation of the mammalian pineal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "by non-rod,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0206427:Rod [Cell]
   861   C1552915:rod [Quantitative Concept]
   861   C1705186:Rod [Medical Device]
   861   C1947942:Rod [Spatial Concept]
   861   C2347970:rod [Quantitative Concept]
   861   C2347971:rod [Quantitative Concept]

Phrase: "non-cone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0206428:Cone [Cell]
   861   C0330095:Cone [Plant]
   861   C2350017:Cone [Spatial Concept]

Phrase: "ocular receptors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.170: Science 284:505-507[Abstract/Free FullText] Marchiafava PL, Longoni B (1999) Melatonin as an antioxidant in retinal photoreceptors. 

Phrase: "Science 284"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "505-507"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450381:507 [Intellectual Product]

Phrase: "[Abstract/Free FullText"

Phrase: "] Marchiafava PL,"

Phrase: "Longoni B (1999"

Phrase: ")"

Phrase: "Melatonin as an antioxidant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0025219:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   770   C1527137:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "in retinal photoreceptors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2350831:Retinal Photoreceptors [Cell]
   861   C0031760:Photoreceptors [Cell]
Processing 00000000.tx.171: J Pineal Res 26:184-189[Medline] Pappolla MA, Chyan Y-J, Poeggeler B, Frangione B, Wilson G, Ghiso J, Reiter RJ (2000) An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease. 

Phrase: "J Pineal Res 26"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031939:Pineal [Body Part, Organ, or Organ Component]
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "184-189"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pappolla MA,"

Phrase: "Chyan Y-J,"

Phrase: "Poeggeler B,"

Phrase: "Frangione B,"

Phrase: "Wilson G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Ghiso J,"

Phrase: "Reiter RJ (2000"

Phrase: ")"

Phrase: "An assessment of the antioxidant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1261322:Assessment [Health Care Activity]
   760   C1516048:Assessment [Activity]

Phrase: "and"

Phrase: "the antiamyloidogenic properties of melatonin"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0871161:properties [Qualitative Concept]
   760   C1292721:properties [Functional Concept]
   726 E C1882134:Property [Conceptual Entity]
   726 E C2347695:Property [Entity]

Phrase: ":"

Phrase: "implications for Alzheimer's disease."
Processing 00000000.tx.172: J Neural Transm 107:203-231 Pierce ME, Besharse JC (1985) Circadian regulation of retinomotor movements. 

Phrase: "J Neural Transm 107"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   812   C0599851:Neural [Functional Concept]
   756 E C0027740:Nerve [Tissue]
   756 E C0027757:NERVE [Tissue]
   756 E C1280541:Nerve [Body Part, Organ, or Organ Component]
   719 E C0027769:nervy [Sign or Symptom]

Phrase: ":"

Phrase: "203-231 Pierce"

Phrase: "ME,"

Phrase: "Besharse JC"

Phrase: "(1985"

Phrase: ")"

Phrase: "Circadian regulation of retinomotor movements."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.173: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.174: Interaction of melatonin and dopamine in the control of cone length. 

Phrase: "Interaction of melatonin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "dopamine in the control of cone length."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.175: J Gen Physiol 86:671-689[Abstract] Rgriny O, Delagrange P, Scalbert E, Atkinson J, LartaudIdjouadienne I (1998) Melatonin improves cerebral circulation security margins in rats. 

Phrase: "J Gen Physiol 86"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1704351:GEN [Quantitative Concept]
   812   C2239486:Gen [Gene or Genome]

Phrase: ":"

Phrase: "671-689"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Rgriny O,"

Phrase: "Delagrange P,"

Phrase: "Scalbert E,"

Phrase: "Atkinson J,"

Phrase: "LartaudIdjouadienne I (1998"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: "Melatonin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025219:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
  1000   C1527137:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "improves"

Phrase: "cerebral circulation security margins in rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205284:Margin [Spatial Concept]
   719   C0229985:margin [Body Part, Organ, or Organ Component]
   719   C1269830:Margin [Finding]
Processing 00000000.tx.176: Am J Physiol 275:H139-144[Abstract/Free FullText] Rem CE, Hafezi F, Reinboth J, Clausen M (1996) Light damage revisited: converging evidence, diverging views? 

Phrase: "Am"

Phrase: "J Physiol 275"

Phrase: ":"

Phrase: "H139-144"

Phrase: "[Abstract/Free FullText"

Phrase: "] Rem CE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827664:CE [Idea or Concept]

Phrase: "Hafezi F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Reinboth J,"

Phrase: "Clausen"

Phrase: "M ("

Phrase: "1996"

Phrase: ")"

Phrase: "Light damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]

Phrase: "revisited"

Phrase: ":"

Phrase: "converging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700387:Converging [Activity]

Phrase: "evidence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "diverging"

Phrase: "views?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:Views [Spatial Concept]
Processing 00000000.tx.177: Graefes Arch Clin Exp Ophthalmol 234:2-11[Medline] Savaskan E, Olivieri G, Brydon L, Jockers R, Kruchi K, WirzJustice A, MllerSpahn F (2001) Cerebrovascular melatonin MT1-receptor alterations in patients with Alzheimer's disease. 

Phrase: "Graefes Arch Clin Exp Ophthalmol 234"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0230467:arch [Body Location or Region]
   799   C0741204:ARCH [Body Space or Junction]
   799   C1315013:CLIN [Intellectual Product]
   799   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "2-11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Savaskan E,"

Phrase: "Olivieri G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Brydon L,"

Phrase: "Jockers R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Kruchi K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "WirzJustice A,"

Phrase: "MllerSpahn F (2001"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: ")"

Phrase: "Cerebrovascular melatonin MT1-receptor alterations in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C1372742:Melatonin Alteration [Physiologic Function]
   711   C1515926:Alteration [Idea or Concept]

Phrase: "with Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.178: Neurosci Lett 308:9-12[Medline] Savaskan E, Olivieri G, Meier F, Brydon L, Jockers R, Ravid R, Wirz-Justice A, Mller-Spahn F (in press) Increased melatonin 1a-receptor immunoreactivity in the hippocampus of Alzheimer's disease patients. 

Phrase: "Neurosci Lett 308"

Phrase: ":"

Phrase: "9-12"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Savaskan E,"

Phrase: "Olivieri G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Meier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Brydon L,"

Phrase: "Jockers R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Ravid R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Wirz-Justice A,"

Phrase: "Mller-Spahn F (in press"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   760   C0439133:(f) [Intellectual Product]
   760   C1553038:[f] [Quantitative Concept]

Phrase: ")"

Phrase: "Increased melatonin 1a-receptor immunoreactivity in the hippocampus of Alzheimer's disease patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0597879:immunoreactivity [Molecular Function]
Processing 00000000.tx.179: J Pineal Res Spencer WH (1996) Ophthalmic Pathology. 

Phrase: "J Pineal Res Spencer WH (1996"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0031939:Pineal [Body Part, Organ, or Organ Component]
   799   C2347379:RES [Finding]
   799   C2349143:Wh [Quantitative Concept]

Phrase: ")"

Phrase: "Ophthalmic Pathology."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   958   C1518542:Ocular Pathology [Biomedical Occupation or Discipline]
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]
Processing 00000000.tx.180: 4th ed Philadelphia, WB Saunders Sugawara T, Sieving PA, Iuvone PM, Bush RA (1998) The melatonin antagonist luzindole protects retinal photoreceptors from light damage in rat. 

Phrase: "4th ed Philadelphia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031525:Philadelphia [Geographic Area]

Phrase: "WB Saunders Sugawara T,"

Phrase: "Sieving"

Phrase: "PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: "Iuvone PM, Bush RA (1998"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0330099:Bush [Plant]
   804   C3538806:Ra [Spatial Concept]

Phrase: ")"

Phrase: "The melatonin antagonist luzindole"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0065275:luzindole [Organic Chemical]

Phrase: "protects"

Phrase: "retinal photoreceptors from light damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C2350831:Retinal Photoreceptors [Cell]
   760   C0031760:Photoreceptors [Cell]

Phrase: "in rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]
Processing 00000000.tx.181: Invest Ophthalmol Vis Sci 39:2458-2465[Abstract] Swaab DF, Fliers E, Partiman TS (1985) The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. 

Phrase: "Invest"

Phrase: "Ophthalmol Vis Sci 39"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1571809:VIS [Therapeutic or Preventive Procedure]
   812   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "2458-2465"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Swaab DF,"

Phrase: "Fliers E,"

Phrase: "Partiman TS (1985"

Phrase: ")"

Phrase: "The suprachiasmatic nucleus of the human brain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C1706993:Nucleus of brain [Body Part, Organ, or Organ Component]
           Brain nucleus
   778   C0038866:Suprachiasmatic Nucleus [Body Part, Organ, or Organ Component]
   778   C1289559:Suprachiasmatic nucleus [Body Location or Region]
   748   C0007610:Nucleus [Cell Component]

Phrase: "in relation to sex,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]

Phrase: "age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "senile dementia."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0002395:Dementia, Senile [Disease or Syndrome]
  1000   C0011268:Senile dementia [Mental or Behavioral Dysfunction]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0392079:Senile [Finding]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.182: Brain Res 342:37-44[Medline] Terman M, Rem CE, WirzJustice A (1991) The visual input stage of the mammalian circadian pacemaking system: II. 

Phrase: "Brain Res 342"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "37-44"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Terman M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Rem CE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827664:CE [Idea or Concept]

Phrase: "WirzJustice A (1991"

Phrase: ")"

Phrase: "The visual input stage of the mammalian circadian pacemaking system"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0205390:Stage [Temporal Concept]
   739   C1300072:Stage [Clinical Attribute]
   739   C1306673:Stage [Qualitative Concept]

Phrase: ":"

Phrase: "II."
Processing 00000000.tx.183: The effect of light and drugs on retinal function. 

Phrase: "The effect of light"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0872206:light effect [Biologic Function]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "drugs on retinal function."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0013227:Drugs [Pharmacologic Substance]
   737 E C1254351:Drug [Pharmacologic Substance]
Processing 00000000.tx.184: J Biol Rhythms 6:31-48[Medline] Tosini G (2000) Melatonin circadian rhythm in the retina of mammals. 

Phrase: "J Biol Rhythms 6"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0871269:rhythms [Finding]
   779 E C1523018:rhythm [Physiologic Function]
   706 E C0031084:Rhythmicities [Temporal Concept]

Phrase: ":"

Phrase: "31-48"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tosini G (2000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "Melatonin circadian rhythm in the retina of mammals."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0008810:Circadian Rhythm [Organism Function]
   770   C1522723:Circadian Rhythm [Biologic Function]
   744   C0871269:Rhythm [Finding]
   744   C1523018:rhythm [Physiologic Function]
Processing 00000000.tx.185: Chronobiol Int 17:599-612[Medline] VivienRoels B, Pvet P, Dubois MP, Arendt J, Brown GM (1981) Immunohistochemical evidence for the presence of melatonin in the pineal gland, the retina and the Harderian gland. 

Phrase: "Chronobiol Int 17"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0063789:INT [Organic Chemical]
   827   C3272375:INT [Intellectual Product]

Phrase: ":"

Phrase: "599-612"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] VivienRoels B,"

Phrase: "Pvet P,"

Phrase: "Dubois MP,"

Phrase: "Arendt J,"

Phrase: "Brown GM (1981"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0546866:GM [Antibiotic,Carbohydrate]
   827   C0678579:Brown [Natural Phenomenon or Process]

Phrase: ")"

Phrase: "Immunohistochemical evidence for the presence of melatonin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in the pineal gland,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0031939:Pineal gland [Body Part, Organ, or Organ Component]
           Pineal
  1000   C1278881:Pineal gland [Body Part, Organ, or Organ Component]
  1000   C1519088:GLAND, PINEAL [Tissue]
   861   C1285092:Gland [Body Part, Organ, or Organ Component]

Phrase: "the retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035298:Retina [Body Part, Organ, or Organ Component]
  1000   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "the Harderian gland."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018597:Harderian Gland [Body Part, Organ, or Organ Component]
   861   C1285092:Gland [Body Part, Organ, or Organ Component]
Processing 00000000.tx.186: Cell Tissue Res 217:105-115[Medline] White MP, Fisher LJ (1989) Effects of exogenous melatonin on circadian disc shedding in the albino rat retina. 

Phrase: "Cell Tissue Res 217"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007634:Cell [Cell]
   812   C0040300:Tissue [Tissue]
   812   C1269647:Cell [Cell]
   812   C1547928:Tissue [Intellectual Product]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "105-115"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] White MP,"

Phrase: "Fisher LJ"

Phrase: "(1989"

Phrase: ")"

Phrase: "Effects of exogenous melatonin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on circadian disc shedding"

Phrase: "in the albino rat retina."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0035298:Retina [Body Part, Organ, or Organ Component]
   827   C1278894:Retina [Body Part, Organ, or Organ Component]
   734   C0684072:albino rat [Mammal]
Processing 00000000.tx.187: Vis Res 29:167-179[Medline] Wiechmann AF, Hollyfield JG (1989) HIOMT-like immunoreactivity in the vertebrate retina: a species comparison. 

Phrase: "Vis Res 29"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1571809:VIS [Therapeutic or Preventive Procedure]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "167-179"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wiechmann AF,"

Phrase: "Hollyfield JG"

Phrase: "(1989"

Phrase: ")"

Phrase: "HIOMT-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001064:HIOMT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412585:HIOMT [Gene or Genome]
  1000   C1848322:HIOMT [Gene or Genome]

Phrase: "like immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "in the vertebrate retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035298:Retina [Body Part, Organ, or Organ Component]
   861   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "a species comparison."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707455:Comparison [Activity]
Processing 00000000.tx.188: Exp Eye Res 49:1079-1095[Medline] Wiechmann AF, Yang XL, Wu SM, Hollyfield JG (1988) Melatonin enhances horizontal cell sensitivity in salamander retina. 

Phrase: "Exp Eye Res 49"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   812   C0015392:Eye [Body Part, Organ, or Organ Component]
   812   C1280202:Eye [Body Part, Organ, or Organ Component]
   812   C1417055:EXP [Gene or Genome]
   812   C2347379:RES [Finding]
   756 E C0029144:optic [Occupation or Discipline]
   756 E C0042789:Ocular [Organism Function]
   756 E C1299003:Ocular [Spatial Concept]
   719 E C0014236:Ophthalmia [Disease or Syndrome]
   719 E C0700042:Oculus [Body Location or Region]

Phrase: ":"

Phrase: "1079-1095"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wiechmann AF,"

Phrase: "Yang"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "XL,"

Phrase: "Wu SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Hollyfield JG"

Phrase: "(1988"

Phrase: ")"

Phrase: "Melatonin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025219:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
  1000   C1527137:Melatonin [Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "horizontal cell sensitivity in salamander retina."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C0234716:Sensitivity, retina [Organ or Tissue Function]
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]
Processing 00000000.tx.189: Brain Res 453:377-380[Medline]

Phrase: "Brain Res 453"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "377-380"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

